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Ten calcium phosphate implant substances (six of natural origin, four of 
synthetic orign) and several bone samples from a single human skeleton have 
been qualitatively and semi-quantitatively characterized with respect to several 
physico-chemical properties. Analysis involved the techniques of X-ray powder 
diffraction, infra-red spectroscopy, inductively-coupled plasma atomic emission 
spectroscopy, atomic absorbtion spectroscopy, and thermal decomposition. In 
addition, a series of adsorption/exchange experiments were conducted in 
which implant and bone sam_ples were exposed to progressively increasing 
concentrations of aqueous Ca2 and Na+ ions. 
X-ray powder diffraction showed that the implants consist of only 
hydroxyapatite while bones contain small amounts of Cao as well. a-Cell 
parameters of the implants of natural origin were larger than those of both 
synthetic implants and bones. The a-cell sizes of the latter two types of samples 
resembled each other. The c-cell sizes were similar for all samples. The degrees 
of crystallinity of all implants were higher than those of bone, possibly indicating 
lower C03 contents in the former. 
%Mass contents of various elements were determined by ICP for implants and 
bones. Statistical analysis on the bone values showed that variation of elemental 
concentrations not attributable to experimental error occurred in bone from 
different regions of the body, but not across the surface of any particular bone. 
Ratios of Ca/P and Mg/Ca were calculated for all samples, and showed 
differences between implants and bone due to higher calcium levels in the former. 
Infrared spectroscopy was used in order to determine %C03 values in all the 
samples. It is suggested that bone .contains higher levels of C03 than the 
implants. This was confirmed by analysis of the shapes of certain bands in the 
spectra of all samples and correlated with XRD results. 
All samples were subjected to heat up to a maximum of 900°C. XRD scans were 
recorded after heating to 650°C and 900°C. Percentage mass losses were also 
recorded at various stages throughout the heating process. Some of the implants 
revealed traces of tricalcium phosphate (/3-TCP) and Cao after heating to 900°C. 
All bones revealed traces of Cao after heating to 900°C. a-Cell parameters were 
calculated for all samples and revealed very slight changes in size. Implants 
exhibited most of these changes after heating to 650°C, while bones did so only 
after heating to 900°C. 
Surface chemistry studies further confirmed chemical differenc]s between 
implants and bone by virtue of the fact that neither exogenous Ca + nor Na+ 
adsorbed/exchanged with ions in the implants, while bone exhibited a clear 
saturation curve for each exogenous ion. 
It is suggested that the techniques and experiments described in this thesis might 
be utilized by other investigators in the hope of establishing guidelines for the 




1.1 THE NEED FOR IMPLANT MATERIALS 
It has always been an appealing possibility for mankind to be able to replace 
damaged body tissue with · foreign materials. As a consequence, materials 
science has progressed in recent years to include the development of new porous 
solids for prosthetic applications, especially for synthetic teeth and bone 
replacement. 
Unlike lower life forms, the human body is substantially limited in its capaCity to 
regenerate components that are lost, damaged or diseased. Furthermore, there 
are great problems associated with implanting foreign substances within the 
human body and these tend to persist even though much work has been done in 
this field. Ironically, the remarkable improvement in medical techniques during the 
past decade has only further aggravated the situation, as many severely injured 
patients now have higher survival rates, and this results in a growing population 
with serious disabilities (Cur62). Autogenous transplants (Cur62), a method 
whereby living tissue of one part of the body is used to repair tissue of another part 
of the same body, are usually successful, but there is an obvious restriction on the 
quantity of material available. This type of bone tissue graft is therefore only feasible 
for rather minor repairs. In the case of homologous transplants, bone tissues are 
taken from another animal of the same species and inserted. However, only in 
unusual instances are these tissues accepted by the recipient's body (Cur62). The 
dilemma persists even for transplants involving bone tissues from a donor of a 
different species. It seems that the root of the problem lies with the organic 
matter present in the foreign bone tissue: it cannot be removed completely, or 
even in minor amounts, and hence causes rejection when implanted in the human 
body (Wic66). 
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For a long time prosthetics ·technology was more advanced than prosthetics 
science. In other words, practitioners knew how to make an implant but had no 
understanding as to why it functioned. The situation has now been reversed by 
the advent of engineering studies. Scientists can determine what materials are 
needed for successful implant prostheses. Fundamental aspects such as tissue 
reaction, whether favourable or adverse, stress distribution as a function of 
geometry, and factors promoting tissue attachment have gained greater clarity. 
Today, calcium phosphate (hydroxyapatite Le.HA) implants are being widely used 
(Ell69,Web93,Sar86,LeGe88a). There are different forms of these available, each 
incorporating varying ratios of different crystal phases. 
The application of calcium phosphate materials as bone substitutes can be traced 
as far back as 1920, when Albee reported that a triple calcium phosphate 
compound used in a bony defect promoted osteogenesis or new bone formation. 
In 1969, Levitt et al (Lev69) and in 1971,Monroe et al (Mon71),reported a method for 
the preparation of a calcium phosphate ceramic, mainly calcium-fluor-apatite, and 
suggested it for the use of dental and medical implantation. Much progress has 
been made since those pioneering days, and it is largely through the simultaneous 
but independent efforts of various researchers in the USA and in Europe 
(LeGe88a), that the potential of these ceramics as bone grafts or substitutes in 
dentistry has been furthered to the extent that they could become commercially 
available. At present there are several commercial outlets in the United States as 
well as in Europe that are marketing these materials under various names 
depending upon their composition and function (See "TYPES OF CERAMIC 
IMPLANTS AVAILABLE" p.8) 
Before studying the function of these materials within the human body, the 
structure, formation and function of bone tissue must be considered. 
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1.2 BONE AND ITS STRUCTURE: 
The composition of bone is mainly a tough organic matrix that is greatly 
strengthened by deposits of calcium salts (Mor66). The matrix content in average 
bone is 70% while that of salt is 30% (Mor66). It is only newly-formed bone that 
differs appreciably from this ratio in that it contains a considerably higher 
percentage of matrix in relation to salts. 
A closer investigation of the matrix reveals that it consists of about 90 to 95% of 
collagen fibres. The remainder is a homogenous medium called "ground substance" 
(For87 ,Sel88). The collagen fibres extend primarily along the lines of tensional 
force, that is, the lines of greatest stress in the bone. These fibres lend the bone its 
great tensile strength (Cur62). 
On the other hand, the bone salts within the organic matrix of bone are 
composed principally of calcium phosphate, otherwise known as hydroxyapatite: 
Each bone crystal is about 400 A long, 10-30 A thick and 100 A wide and is shaped 
like a long, flat plate (Mor66). The relative ratio of Ca to P can vary markedly under 
different substitutional conditions; on a mass basis it ranges from 1.3 to 2.0. 
(For87, Gan89). 
Mg2 +, Na+, K+ and col- ions are also present among the bone salts (Mor66). 
These ions are believed to be conjugated to the hydroxyapatite crystals rather 
than to be organized in~o distinct crystals of their own. Many different types of 
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ions can conjugate to bone; these include ions normally foreign to bone, such as 
Sr2 +, Pb2 +, Au+, as well as many major radioactive ions. 
1.3 TENSILE AND COMPRESSIONAL STRENGTH OF BONE 
In order to understand how the mechanical properties of bone are produced, 
attention has to be focussed on the way in which collagen and apatite combine. 
Every 640A along the length of a collagen fibre there is a repeating periodic 
segment, adjacent to each of which lie hydroxyapatite crystals, bound tightly to 
it (Sel88). It is this strong bonding that prevents "shear" of the bone and lends the 
bone its inherent strength. In addition to this, the segments of adjacent collagen 
fibres overlap each other, thereby creating an overlap between the hydroxyapatite 
crystals. Like the collagen fibres of tendons, those of bone have great tensile 
strength but low elasticity, while the calcium salts, which are similar in physical 
properties to marble, have great compressional strength (Cur62). Hence it is more 
likely that the calcium salts (apatites) - effectively the ceramic component of bone 
- would have low tensile strength in bulk, since ceramic materials are 
characteristically stronger in compression than in tension (Cur62). Collagen and 
apatite, however, when combined, produce a third material, called bone. Bone 
has a high tensile strength (about 15000 lb./in2) and even higher compressive 
strength (about 25000 lb./in2) (Cur6f Any cracks that develop in the structure 
will spread only under the influence of very high stresses. Once they do spread, 
they will immediately leave the apatite crystals and enter the collagen, which will 
deform under their influence but not rupture. Thus, it can be appreciated that it is 
the combination of collagen with apatite that makes the structure of bone so tolerant 
to stresses. 
. -- ·-·-
Bone has a high tensile strength (!bout 1.03*10~·kPa) and even higher 
compressive strength (about 1. 72*10 kPa) (Cur62). 
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1.4 BONE AND BIOMATERIAL 
When hard tissue is replaced, or limb prostheses permanently attached, or 
even teeth implanted, the critical requirement is that the biomaterial must interface 
with bone. The natural response of healing tissue to an implanted foreign body is to 
encapsulate it in scar. Thus, contrary to natural healing, continuity of tissue is 
never fully restored as long as the implant remains to occupy space which would 
otherwise be filled by scar. The root of the problem thus lies in the fact that all 
man-made substances differ from bone in some or other respect. 
1.5 BODY RESPONSE 
The greatest obstacle for the successful implant of prosthetic devices in the body 
stems from the body's elaborate immune system. It is extremely efficient in 
identifying foreign objects, either seeking to destroy the intruder, or if unable to do 
so, then at least to neutralize it in some way. Phagocytic cells are available to 
digest the smaller particles of foreign matter such as bacteria and viruses (Sch68). 
These phagocytic cells can also be prompted into response by chemical stimuli. 
Three grades of response can follow in such a case: 
Grade 1: If there is an absence of corrosion, a very thin membrane separates the 
implant from surrounding healthy tissue; 
Grade 2: If small areas of corrosion are detectable, discoloration of the 
surrounding tissue occurs. The surrounding membrane is then thicker; 
Grade 3: If there is severe corrosion, extensive discoloration of the surrounding 
tissue occurs. Thick scar tissue surrounds the bone and numerous inflammatory 
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cells are present. Many cells die, and pus is created. If this is not treated in due 
course, the patient may die. 
Healing around an implant as outlined above, involves its total encapsulation. 
When the implant is partially exposed, healing may cause its rejection because 
the surface tissue (i.e. epithilium) will grow into the capsule-implant interface 
(Dav68). Granulation tissue is far more susceptible to destruction by sepsis and 
irritation than is cutaneous epithilium. It is surmised (Dav68), that a partially 
exposed prosthesis will be unstable as long as there is no secure, real bond 
between the surface of the implant and the connective tissue capsule. 
It is apparent from the above discussion that the problem· of biocompatibility 
imposes a severe restriction upon the choice of materials to be used in prosthetic 
applications. 
1.6 PREREQUISITE PROPERTIES OF IMPLANT MATERIALS: 
As we have seen from the previous discussion, the most important property of an 
implant material is its compatibility with body tissues and fluids. In order to blend 
with its surroundings in the human body, the implant must be non-toxic and non-
irritating to the adjacent cells (Gro66). 
Biodegradation of implant materials is characterized by alterations in the 
physicochemical properties of the material after implantation (LeGe88b). Factors 
that tend to increase the rate of biodegradation include ionic substitutions in the 
apatite lattice, like co32-, Mg2 +, and Sr2+ (LeGe88b). In the case of calcium 
phosphate ceramic implants, physical changes may include disintegration, loss of 
mechanical strength and changes in porosity; chemical changes that may occur 
7 
include dissolution, formation of other CaP phases, and also possible 
transformation of these phases on the ceramic surfaces. 
1. 7 SURGICAL USES 
Implant materials can be used in two different applications: (Gro66) 
1) fixation devices, and 
2) prostheses. 
The former have the primary role of serving as "splints" during healing ~nd 
regrowth of damaged· bone tissue, whereas the latter have generally stronger 
mechanical requirements, for the following reasons: 
i) the prosthesis must retain adequate strength for a long time, and 
ii) the strength that it retains must be sufficient so as not to impose any 
restrictions upon the activities of the recipient (Gro66). 
In the case of a fixation implant the surgeon may order a restriction on activities, 
such as walking, but only for enough time to allow reasonable healing. A hip 
prosthesis, for example, which is used to replace the head of the femur, has to be 
capable of tolerating loads of up to six times the body weight, depending upon the 
individual's activities (Wei68). Fixation devices, such as plates, nails, pins and 
staples are not designed for weight-bearing use; but rather to hold bones in 
proper alignment until healing occurs. They should be sufficiently strong to serve for 
their intended purpose as well as withstand occasional overloading. 
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The unique feature that commends calcium phosphates as implants is their ability 
to become directly bonded to bone (Cal84). This means that the bone forms or 
grows directly on the implant surface, producing a continuum of calcium substance 
from itself, through the interface and into the implant. The strong bond associated 
with these implants has been attributed to a "bonding zone" described as dense 
"amorphous" material (LeGe88a,Dac90). Thus, stimulation of bone growth by the 
implant occurs. 
Another benefit of the calcium phosphate implants is that they can be made 
. resorbable so that they can eventually be entirely replaced by host bone. 
Many investigators (Heu88, LeGe88a, LeGe88b, Dac90) have studied the changes 
that occur with time after the implantation has been completed. The exact 
mechanism for the formation of the "bonding zone" is not known (LeGe88a). The 
ultrastructural characterization of the interface is yet to be completed. 
1.8 TYPES OF CERAMIC IMPLANTS AVAILABLE 
There are several types of. calcium phosphate ceramic implants (Table 1.1) 
available commercially today, each differing from the next with respect to 
preparation and composition (LeGe88a). 





1. Calcium Hydroxyapatite. 





Periograf, Durapatite etc. 
2. ,8-Tricalcium Phosphate. 
Commercial names: Synthograf, Aug men. 
· 3. Biphasic Calcf um Phosphates 
(mixture of HA and ,8-TCP). 
Commercial name: Triosit. 
1. Coralline HA: coral (Porites) 
hydrothermally converted to HA. 
Commercial name: lnterpore 200 
2. Sintered bovine bone. 
Commercial name: Bio-oss. 
1. Prepared by melting together 
Si02,Na20/K20 +Cao, and P20 5. 
Commercial names: Bioglass, 
· Ceravital. 
1.9 DIFFERENCES OF CERAMICS TO OTHER IMPLANTS 
9 
The fundamental difference in the choice of ceramic implant materials as 
opposed to other materials (such as metals, alumina, carbons.etc.) is that its 
selection is not based on inertness criteria to prevent a response from the · body, 
but rather on its ability to provoke a reaction to their presence. Thus there are 
terms classifying the metal implants (and others mentioned above) as "bioinert" 
and the ceramic materials as "bioactive" (LeGe90). A cerar;nic must therefore have 
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a chemical composition and a microcrystalline structure almost identical to bone to 
make such a bioactive nature possible (Web73). 
A variety of bioinert materials is available commercially, but recently, a method of 
application has been suggested for possible future use: a metal implant is coated 
with a layer of HA or Bioglass, thus combining the strength of the metal with the 
flexible adaptivity imposed by the HA or Bioglass coating (LeGe88a). These coating 
processes may have a great influence upon the properties of the newly-formed 
metal implant when compared to the presently-available forms, especially with 
respect to their biodegradability. 
1.10 DENSE vs POROUS CALCIUM PHOSPHATE MATERIALS 
To differentiate between the two terms, it is necessary to consider the materials on 
the basis of gross physical properties. Materials which are called "dense" are 
actually micro-porous as a consequence of · the sintering conditions (i.e 
temperature and duration of sintering) under which they were prepared. On the 
other hand, porous materials are those that are macro-porous in nature, and this 
is due to deliberate chemical processing (e.g addition of an organic component, 
such as naphthalene or H20 2, followed by volatilization of this component before 
finally sintering) (LeGe88a). Materials derived from corals i.e. coralline 
hydroxyapatite, are macro-porous as a result of deliberate retention of the 
properties of the coral's CaC03 skeletal structure during the hydrothermal 
conversion to hydroxyapatite (Don69,Web71,Roy74,lnt85,Sar86). The mechanism 
of bone attachment occurring with the macro-porous structure is that it allows 
penetration of body tissue through it and as a result, becomes an integral part of it 
(Web71). Macro-porosity with pores of 150µm in diameter is considered ideal for 
tissue ingrowth (LeGe88a), since this matches the macro-porosities in human 
spongy bone. 
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Both porous and dense materials show strong attachment to bone. The dense 
material has been reported to have a greater rate of healing compared to 
standards, while the porous materials have exhibited slower rates of healing within 
bony pocket confines (LeGe88a). Studies of their biodegradability have revealed 
that the dense variety biodegrades at a slower rate than the porous type, and 
mechanical strength investigations have revealed that, the dense material is 
stronger than the porous type (LeGe88b). 
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1.11 AIM OF PRESENT STUDY 
From the aforegoing it is appare_nt that the biocompatibility of implant materials is 
of fundamental importance in determining whether such materials will serve 
usefully and function correctly. Biocompatibility, in turn, is probably dependent on 
numerous factors, among which the physicochemical nature of the implant 
materials must play a key role. It seems reasonable to suggest that of even greater 
importance is how these physicochemical properties compare with those of the 
bone in which they are to be implanted. Herein lies the aim and objective of the 
present study: to characterize, on a qualitative basis, the physicochemical nature 
of some calcium phosphate implant materials as well as some human bone tissue. 
In defining these objectives it is recognized that the physicochemical properties of 
bone may vary from site to site within the same bone sample as well as within 
bones from different locations in the human body. Moreover, variation within 
bones from different individuals as well as male-female differences may also be 
expected. It is intended that the site-to-site variation and different location-type 
variation be addressed in the present study. However, inter-human variation of 
bone properties is beyond the scope of this study. 
1.12 MATERIALS 
\ 
1. 12.1 Implant materials 
Ten ceramic implant materials were supplied by the Department of Orthopaedic 
Research, Brigham and Womens' Hospital, Harvard Medical School, Boston, USA. 
Of these, six were of natural origin, while the remainder were of synthetic origin. 
Details are given in Table 1.2 below. 
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TABLE 1.2 : List of ceramic implant materials used 
Implant Commercial Description 
number brand 
1 S 26/T900 Preparation: 
calcination at 900F 
2 OsteoGen * Resorbable ; 
particle size: 
300-400 microns 
3 Porex Pha Resorbable * 
partide size: 
300-400 microns 
4 C O/T900 Preparation: 
calcination at 900F 
Origin: anorganic bovine bone 
5 Bio-Oss Particle size: 1-2mm 
Origin: anorganic bovine bone 
6 Bio-Oss Particle size: 1-2mm 
Origin: anorganic bovine bone 
7 Calcitite Type: calcium phosphate ceramic 
Mesh size: 40-60 microns 
Non-resorbable * 
8 Calcitite Type: calcium phosphate ceramic 
Mesh size: 20-40 microns 
Non-resorbable * 
9 lnterpore 500 Type: coralline HA 
Preparation: hydrothermal 
conversion of "Porites"** 
Pore size: 500 microns 
10 lnterpore 200 Type: coralline HA 
Preparation: hydrothermal 
conversion of "Porites"** 
Pore size: 200 microns 
* "Resorbable" specifies that the material implanted becomes absorbed by the bone, thereby 
adopting a bone-like nature. 
** "Porites" are a type of sea-coral. 
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1.12.2 Bone specimens 
The bone specimens were provided by the Department of Anatomy, UCT Medical 
School and were obtained from one human cadaver. The subject was a male, aged 
64. The date of death was 12th of January 1985 (at Groote Schuur Hospital), and 
the cause was cancer of the bronchus. 
The sites sampled are listed in Table 1.3. 









... Location origin 
Distal-medial segment of left humeral head 
- cancellous bone 
Medial portion of di.stal diaphysis of left humerus 
- compact bone 
Antero-lateral segment of left patella 
- sessamoid bone 
Transverse process of 9th thoraci9 vertebra 
Anterior (sternal) half of left 10th rib 
Cranial vault pieces from antero-inferior 
aspect of right parietal bone 
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2. TECHNIQUE· INSTRUMENTATION AND METHODOLOGY 
2.1 X-RAY POWDER DIFFRACTION 
The basic principle of this method is that a powdered specimen of crystalline 
material is bathed in a beam of monochromatic X-rays which are diffracted by the 
various planes of atoms and which are then recorded as a spectrum on a strip 
recorder or photographic film. The diffraction pattern so obtained is a one-
dimensional record of peak intensities as a function of diffraction angle (29). It is a 
unique characteristic of the crystal and is similar to a human fingerprint in that it is 
very useful for identification purposes. 
The success of a diffraction experiment depends on the proper preparation of 
the sample under study. Many different methods of sample preparation have 
been devised for many different purposes. Ideally, samples for quantitative X-ray 
diffraction analysis should be prepared in such a way that particle/crystallite size 
distributions within the sample are uniform and matched in size (Jen81). The terms 
"crystallite" and "particle" size may not always be synonymous. Crystallite size 
refers to the size of the individual domains which diffract the X-rays in a certain 
coherence. Particle size refers to the grain size in a powdered specimen. Thus, 
particle size can be many time the crystallite size for a sample since individual 
grains may be made up of many crystallites (Jen81,Rah84). In general it is the 
crystallite size which is important when considering the orientation effects in the 
sample, the peak shapes and the noise levels in the background. 
Preferred orientation has long been considered to be the primary source of 
systematic error in quantitative X-ray diffraction analysis (Rah84, Jen81). For 
truly quantitative X-ray diffraction analysis, it is necessary to use randomly 
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orientated specimens because of the dependence of the peak intensities on 
particle/crystallite orientation. Preferred orientation effects can be reduced by 
employing the side-drifting or end-loading technique (Rah84,Geh83). Gehringer et 
al. (Geh83) have reported reproducibility figures of 1 to 3% for this technique, 
which is very acceptable. Consequently, it is this technique which was used in the 
present study. 
A common shortcoming of X-ray diffractometry is the failure to reveal the presence 
of constituents in mixtures when these occur in minor concentrations. This is 
attributable to four factors (Geh83): the first is that a constituent whose 
concentration is less than about 10% will give only a weak diffraction pattern 
which may be (partly) obscured by the major component. The second arises in 
those cases where several constituents have common reflections in the diffraction 
pattern which may make it very difficult, if not impossible, to distinguish one 
constituent from another. A third source of error may originate from incorrect 
sampling of the specimen to be tested in that certain specific deposits may be 
physically missed. The final source of error lies with the instrument itself, which may 
impose certain limitations upon the resolution of reflections. For example, use of 
photographic film (as opposed to strip chart recorder) may preclude the 
detection of low 29 reflections. 
, 
X-ray powder diffraction was selected for use in the present study to achieve the 
following objectives: 
(i) to identify which crystal phase of calcium phosphate is present; 
(ii) to determine unit-cell parameters (which may aid in the detection of crystal 
lattice substitutions); 
(iii) to measure the degree of crystallinity. 
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(iv) to monitor changes in crystal parameters and crystallinity after thermal 
treatment (see Thermal Decomposition, p.40). 
2.1.2 Equipment and operating conditions 
Portions of -0.05g of each of the ten implant materials were roughly ground with a 
mortar and pestle. These were then progressively passed through a series of 
stainless steel sieves of size 53,45,and 38µm respectively. Thereafter, samples 
were packed into aluminium trays using the end-loading technique. After 
recording a diffraction spectrum, each sample was re-loaded and a duplicate 
spectrum recorded. A diffraction pattern for an empty .aluminium plate was also 
recorded to determine its characteristic peaks. The bone samples were treated in 
the same way. 
Diffraction patterns were recorded using a Philips PW 1050/70 automatic X-
ray powder diffractometer fitted with monochromator and scintillation counter with 
pulse height selection. A PW2233/20 Cu normal focus tube was run at 40kV and 
40mA and was used with 1° divergence and scatter slits. Peak positions and 
intensities were recorded on a strip chart while scanning the sample through a 29 
range of 20-54°. 
Chart settings were: 
Scan rate: 2 °/min 
Chartdrive: 2cm/min 
I 
Range: 4000 cm/sec 
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2.1.3 Spectra analyses 
a] Crystal Phase 
The spectra obtained for the samples were examined for the presence of 
hydroxyapatite and ,8-tricalcium phosphate (Whitlockite). 
b] Unit cell parameters 
In order to study· substitution effects in the apatite structure, unit-cell 
parameters have to be calculated. These have been reported to alter significantly 
as a result of various substitutions (LeGe65,LeGe67,LeGe69,Mco65). Unit cell 
measurements of apatite crystals (HasX) were obtained from the 002 and 300 X-
ray diffraction lines. Since the structure is reported to be hexagonal, only the sizes 
of a- and c-axes needed to be measured (since b=2a) (You75,Mco65,Mac72,Ell73). 
® 
The expressions used to calculate the lattice parameters are: 
c(A) = 2(d002) 
a(A) = 3(d300)/sin60 (HasX) 
A list of the cell-measurements for the samples tested is provided under the 
RESULTS section (p.52). 
No internal standard was used. 
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c] Crystallinity 
When substitution of certain ions occurs in the crystal, the degree of crystallinity 
may alter, depending upon the amount and type of substituent present (Sob49, 
Mco65, LeGe73 ,Blu81,LeGe83,LeGe8'4). For example, the presence of carbonate 
in the apatite crystal can decrease the crystallinity, whereas the presence of 
Fluoride can increase it (Pos63, LeGe65,LeGe67,You75,LeGe80,LeGe87). The . 
crystallinities of the various samples were calculated from the half-height width of 
the peak due to the 002 reflection (HasX, Mco60, Sil86). The values obtained in 
this manner are not absolute values, but are rather used as relative comparison 
parameters and provide an IND/CATION of the degree of crystallinity prevalent in 
each of the samples. Further effects of substitutions on crystallinity will be covered 
under the DISCUSSION section of this study (p.84). 
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2.2 ICP-AES TECHNIQUE INTRODUCTION 
Inductively coupled plasma atomic emission spectrometry (ICP-AES), was 
conceived in the early 1960's and is now being used in a wide variety of applications 
(Pin78,Tho83,Mon87). The ICP is an effective source of atomic emission which can 
be used for the determination of a wide variety of elements; hence its current 
popularity among scientists. The major constituent parts of an ICP system are 
identified as (Bar81,Tho83): 
(i) the sample introduction system (nebulizer); 
(ii) the ICP torch; 
(iii) the radio frequency generator; 
(iv) the transfer optics and spectrometer; and 
(v) the interface and computer. 
In the simplest form of the equipment, a solution of an element whose 
concentration is to be determined, is ·introduced into the ICP torch as aqueous 
aerosol. The light emitted by the atoms or ions in the ICP is converted to an 
electrical signal by a photomultiplier in the spectrometer. The intensity of this 
electrical signal is compared to a previous measured intensity of a known 
concentration of the element, and a final concentration is computed. A schematic 
representation of a typical ICP system is given in Fig.2.1 (Tho83). 
~- - - . 
Fig.2.1 : Schematic diagram of a simultaneous ICP system 
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fitted with·"· two monochromators of which 
monochromator B in· Table_ 2·. 2,' page 31. - -.... 
Plasma-200 spectrometer 
one operates in vacuum: 
- tAllieer AAalytical Systems} This instru-ment is an updated version of the IL 
Plasma-100 previously described in detail by Smith et al. (Smi83,Wan86). 
2.2.2 Overall Description 
The Plasma-200 is a self-contained ICP spectrometer system that consists of a 
power regulator, radio frequency power amplifier, sample pump, nebulizer and 
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spray chamber, torch, two monochromators - the standard air path and a vacuum 
monochromator which allows the observation of emission lines in a vacuum 
below 300nm (Wan86, AllM). The_ computer monitors, interrupts, controls switches 
and levels, and performs other input/output functions such as signal measurement, 
processing and the presentation of analytical results. A schematic representation of 
an inductively-coupled plasma source is given in Fig 2.2 (Bar81 ). 





"--- load coil 
plasma torch 
sample aerosol 
By definition, a plasma is a gaseous mixture in which a significant fraction of the 
atomic or molecular species originally present is in the ionic form 
(Lee83,Smi83,Tho83). The plasma employed for emission analyses generally 
consists of a mixture of argon ions and atoms. When a test sample is injected into 
this medium, atomization occurs as a consequence of the high temperature, which 
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may be as great as 1x104K (Bar81,Smi83). Argon ions are formed in a plasma and 
are capable of absorbing sufficient power from an external source to maintain a 
sufficiently high temperature to continue the ionization process. 
The argon stream flows through three concentric quartz tubes at a rate of between 
15 and 20 litres/min. The diameter of the largest tube is 2.0cm. At the top of this 
tube and surrounding it is a water-cooled induction coil that is powered by a two-
kilowatt radio frequency generator (AllM). A spark from a Tesla coil causes 
ionization of the flowing argon. The resulting ions and their associated electrons 
then interact with the fluctuating magnetic field produced by the induction coil. 
This interaction causes the ions and electrons within the coils to flow in the closed 
·annular paths. Their resistance to this movement causes ohmic heating. Because 
the temperature of the plasma created in this way is very high, thermal isolation 
from the outer quartz cylinder is needed. This isolation is achieved by allowing 
argon to flow tangentially around the walls of the tube. The flow of this stream is 14 
to 20 liters/min and cools the inside walls of the center tube. 
2.2.3 Sample injection 
The peristaltic pump is computer-controlled and varies the sample input flow rate 
from 0.1 ml/min to the maximum allowable value (approx. 2.2mljmin) (Smi83). 
When the sample is introduced, the computer automatically increases the pump 
rate to reduce the time required to introduce the sample into the plasma.The 
nebulizer is of cross-flow design with sapphire gas and sample orifices to reduce 
nebulizer clogging and to provide a surface that is resistant to all common 
solvents (Bar81,Tho83,Mon87). The sample may be an aerosol, a thermally 
generated vapour, or a fine powder. 
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The most widely used apparatus for sample injection is similar in construction to 
the nebulizer employed for flame methods. Here the sample is nebulized by the 
flow of argon, and the resulting finely divided droplets are carried into the 
plasma. 
2.2.4 Plasma Appearance and Spectra 
The typical plasma has a very intense, brilliant white, nontransparent core 
topped by a flame-like tail· (Mah83,21,AllX). The core, which extends a few mm 
above the tube, consists of a continuum upon which is superimposed the atomic 
spectrum for argon. The source of the continuum arises from recombination of 
argon and other ions with electrons. In the region above the core, the continuum 
fades, and the plasma is optically transparent. Spectral observations are generally 
made at a height of 15 to 20mm above the induction coil (Lee83b,Bra83,Wan86). 
Here, the background radiation is remarkably free of argon lines and is well 
suited for analysis. Many of the most sensitive analyte lines in this region of the 
plasma are from ions such as Ca(I), Ca(ll), Cd(I), Cr(ll), and Mn(ll). 
2.2.5 Analyte Atomization and Ionization 
There is not a great temperature variation along a typical plasma source. For 
example, at a height close to the r.f.coil, the temperature is as high as 1x104K, 
whereas at a height of 25mm, the temperature is 6x103K (Tho83,Mon87,21). 
Because of these high temperatures, atomization is more complete and there are 
fewer interference problems due to dissociation reactions. 
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2.2.6 Quantitative Applications of ICP-AES 
When preparing for quantitative analysis, extreme care must be taken to control the 
many variables involved in sample preparation. In addition, a set ·of . carefully 
prepared standards for calibration purposes is required (Pin78,Bra83). These 
-
standards should closely resemble the composition and physical properties of the 
samples to be analysed. 
2.2. 7 Standard samples 
. In some instances, standards can be synthesised from pure chemicals. On the 
other hand, a large number of carefully analyzed metals, alloys, and mineral 
materials have been analyzed by the NBS (National Bureau of Standards), and 
these are available as standards. Finally, standards are also available from a 
number of commercial companies. 
2.2.8 Operation 
a] Optimisation 
Once suitable standards have been chosen and prepared and the samples are 
ready for analysis, optimisation of the instrument is of critical importance. Usually 
five parameters enable the analyst to set the machine for optimal analysis 
(Pin78,Bra81,Smi83).These are: 
(i) torch power; 
(ii) plasma gas flow; 
(iii) torch observation height; 
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(iv) carrier gas flow rate; 
(v) · nebulizer driving pressure. 
After setting the above conditions, only the selection of the spectral line for each 
of the relevant elements remains. This is usually based on information from the 
literature and by using line coincidence tables (Mah83), in which possible 
interferences by other elements present in the samples are considered. 
b] Detection Limits 
The detection limit is usually defined as "the analyte concentration which . will 
produce a net line intensity that is twice or three times (IUPAC recommendation) 
greater than the standard deviation of the background signal for a blank solution 
· not containing the analyte, with a minimum of ten successive measurements" 
(Dea75,Fuw82). Three-fold differences in analyte figures are not significant, as day 
to day variations in the instrument as well as in operator skills can easily alter 
values (Mah83,Lee83b). Often however, unrealistically low detection limits are 
reported. These invariably are obtained by using an excessively large number of 
readings and long integration times (Wan86). Thus, proper lower limits of detection 
have to be established for each study. The upper concentration limit is the 
maximum concentration that can be aspirated without the signal intensity saturating 
the photomultiplier tube of the detection system (Mah83). Choice of a less 
sensitive line or use of a less efficient observation height, as well as sample 
dilution can help to alleviate this problem. 
c] Interferences 
In most analyses, there are generally two types of interferences - additive and 
multiplicative (Bar81,Bra83). The first type causes a change in the intercept of the 
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calibration curve. This occurs when the sample constituent gives rise to a signal 
that adds to the analyte intensity. The second type causes a change in the slope of 
the calibration curve and occurs when a sample constituent enhances or 
suppresses the analyte signal without creating a signal of its own (Mah83). Spectral 
interferences are generally additive and can occur as a result of emission from 
OH bands, for example, or even stray light. These interferences can often be 
eliminated by correct wavelength selection. If, however, spectral interferences 
cannot be avoided, correction schemes based on the measurement of the 
concentration of interfering elements must be used. True background shifts can be 
allowed for with background correction facilities such as those available on the 
Plasma-200 instrument used in this study: after measurement of the background 
intensity on one or both sides of the analyte peak, this "base line" is automatically 
subtracted from the emission line. As a result of this facility, it is apparent that 
spectral interference plays only a minor role in ICP-AES. 
Chemical interferences are comprised of the "classical stable compound-
formation" and ionization interferences (Tho83,Mon87). These are caused by 
chemical interaction of the sample constituents and are multiplicative. 
Finally, physical interferences may arise from direct environmental effects( e.g 
temperature and pressure variations) on instrument performance, and become 
apparent as drift and increased noise levels during analysis (Bar81). These can be 
minimized by avoiding large variations in dissolved solid levels and solvent type. 
d] Wavelengths 
The wavelength chosen for the analytical procedure is critical to the success of the 
investigation. It must display minimal spectral interferences as well as sufficient 
sensitivity to ensure detection (Bar81,Tho83). 
28 
e] Advantages of ICP 
There are several advantages of using ICP relative to other spectre- metric 
techniques. These include: 
(i) its applicability to the analysis of most elements; 
, 
(ii) simultaneous or rapid sequential multi-element determinations are 
possible; 
(iii) atomization occurs in a chemically inert environment, which should 
enhance the lifetime of the analyte; 
(iv) effects such as self-absorbtion and self-reversal are not encountered as a 
result of the uniform cross-section temperature of the plasma; 
(v) detection limits are comparable to other spectrometric techniques and are of 
acceptable precision and accuracy. 
f] Objectives of using ICP-AES · in the present study. 
. There are several objectives associated with this part of the study: 
(i) to determine concentrations of the major (Ca and P) and some of the minor 
(Na, Mg, Sr, K, Fe, and Zn) elements in all samples; 
(ii) to calculate useful parameters from these, such as Ca/P and Mg/Ca 
ratios so that these may be compared with values published for similar 
materials; 
(iii) to determine whether elemental concentrations vary laterally across a bone 
surface; 
(iy) to determine whether elemental concentrations vary in different bones; 
and 
(v) to compare ICP data with results obtained from the XRD and I~ studies. 
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2.2.9 Sample preparation 
Portions (1.0-1.5g) of powdered bone and implant sample were separately weighed 
into (1 OOml) Erlenmeyer flasks and 3-4ml of concentrated nitric acid was added 
(Bar81,Mah83,Wan86). The mixture was heated slowly on a hot plate. Hydrogen 
peroxide (30%) was added (dropwise to prevent foaming and loss of sample) until 
all organic material was destroyed (Mah83). Approximately 15-30 mins. was 
required for complete dissolution. 
After cooling, the solution was transferred to a 50ml volumetric flask and diluted to 
volume with 18mohm (high-purity) water. A 1ml aliquot of this solution was placed 
into a 100ml volumetric flask and again diluted to volume with 18mohm water. 
These final dilute solutions were prepared in order to analyse for elements such 
as Ca, Mg, and P which are expected to be present in n:iuch higher 
concentrations than other elements. 
Care was taken throughout the preparation to limit contamination from , dirty 
glassware by soaking the latter overnight in a soap solution, followed by rinsing for 
3-4hrs in a dilute nitric acid bath. All solutions used during the preparation were of 
analytical reagent grade. 
The sampling technique for bone was, however, somewhat more intricate than that 
for the implant materials in order to meet the objectives of this study. To acquire 
representative samples of each bone from several regions of the body, two sites of 
that bone were sampled. These were analysed in duplicate using the ICP. Three 
readings were taken for each determination. Data were labelled (Rx,Sy.Az) 
where Rx refers to the origin of the bone within the body (e.g rib, skull,etc.); S 
refers to one of two possible sites within each bone; Ax gives the analysis number. 
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2.2.1 O Experimental conditions 
Table 2.1 below presents a list of the operating c~nditions under which all studies 
were carried out. The most sensitive prominent spectral lines for each respective 
element were studied for potential interferences. These effects on the analyte 
emission were evaluated by obser\iing the recorded intensity profiles on a video 
display. This was done by aspiration of a standard solution, using the "restpeak" 
facility for viewing of the signal on the screen, then repeating the procedure for a 
sample solution. In this way, an immediate and overall indication was obtained of 
the concentration of the particular element of interest. In addition, it was established 
whether background correction needed to be applied. Table 2.2 lists the 
wavelengths selected. 
TABLE 2.1 : Operating conditions of Plasma-200 
Power 1.2kW 
Plasma coolant gas flow 131/min 
Sample feed rate 1 ml/min 
Nebulizer driving pressure 206.8 kPa 
Aerosol carrier flow rate 0.41/min 
Pump delay 30 secs 
Peak window 0.067 nm 
Integration time 3 secs 
Observation height 4-30 mm, varied 
Number of readings 3 
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TABLE 2.2 : Wavelength data 
Element Wavelength Background· Monochromator Viewing 
(nm) correction height (mm)* 
Ca 315.89 A 12 
p 213.62 B 
Mg 285.21 B 
Na 589.59 A 30 
Sr 407.77 A 14 
K 766.49 A 4 
Zn 213.86 Rhs B 
Fe 259.94 B 
* viewing height is fixed for channel B (vacuum) 
The concentrations of the various standards prepared are listed in Table 2.3 
below. These were prepared from 1 OOOmg/I stock solutions. 








Mg Na Sr K Fe Zn 
0.10 0.50 0.10 0.10 0.10 0.10 
0.20 1.50 0.30 0.30 0.50 0.50 
0.50 3.00 0.60 0.60 1.00 1.00 
2.2.11 Statistical evaluation 
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In order to meet some of the objectives of this section of the study, a statistical 
analysis was performed on the bone results obtained from the ICP measurments. 
This analysis involved ascertaining whether differences in elemental concentrations 
at different sites within the same bone were attributable to experimental errors or to 
inherent characteristics of the bones. In addition, the nature of differences observed 
between bones of different regions of the body were also examined. In order to 
achieve these objectives, a variance component model was used by applying the 
VARCOMP procedure (Rao73) as described in the SAS User's Guide (Car85). The 
VARCOMP procedure computes estimates of the variance components in a general 
linear model. The "maximum likelihood" method is used. This estimates variance 
components by iterating initial estimates of the components until the log-likelihood 
objective function converges. The presence of random and non-random effects are 
therewith effectively determined (the log-estimates and respective standard errors 
are listed in Table 5, APPENDIX 2). 
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2.3 INFRA-RED TECHNIQUE INTRODUCTION 
Infrared spectroscopy is a well-established technique used in a wide variety of 
applications (law61,Whi66,Ram78). It is based on the principle that when a beam 
of electromagnetic radiation (infrared) is passed through a sample, different 
wavelengths are absorbed to different extents. These are recorded on a chart. ~ 
_.!. - .~ .. ~ "T : ~ (., • ' .' ,. ~ •• ' , ' ' ., ;. • ,) • ' , - ~ ·~ 
The· infrared "''spectrum· c1onsists . ofJ -three. · differeritJ, 
{Sim66,Kno84), .. of which the -''middle" region is of interest 
study. Fig. 2. 3 depict's tne · 'e le.tr.omagnet'ic spectrum. 
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Most organic and inorganic materials show absorbtion yielding a spectrum which 
is characteristic of the particular substance. The infra-red spectrum is thus a 
fundamental property of a compound and may be regarded as its "fingerprint" in 
the same way as the XRD pattern. 
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Infrared spectroscopy has been used successfully as a tool to determine the 
%C03 content of various samples such as tooth enamel, bone tissue, and synthetic 
apatites (HasX, Are75,Fea84). IR absorbtion spectra of apatite are characterized by 
vibration bands produced by OH-, P04
3-, and C03
2- groups (HasX, Are75,LeGE;l81). 
The col- vibrational modes are.given the signals v1, v2, v3, and v4 (LeGe81,Nel82). 
Generally, in hydroxyapatite, col- occurs in three different positions (LeGe67): 
i) adsorbed on the crystal surface; 
ii) in OH- sites, and 
iii) in Pol- sites. 
/ 
About one third to two-thirds of the total C03
2- occurs on the surface. The 
remainder is distributed between P04- and OH-sites in the ratio of 90% to 10% 
respectively. 
a] Carbonate determination from I A-spectra 
In order to determine the %C03 and C03/P04 ratios for a sample, the bands due 
to C03 (875cm·1, 1415cm·
1,and 1460cm-1) and P04 (575cm·
1, 600cm·1, and 
1040cm-1) have to be examined. It is also necessary to calculate the extinction 
coefficient of the carbonate in-plane stretching band at about 1415cm·1 (E1415). 
This is achieved from measurement of baseline (background) transmittance (T 2) 
and peak m?l><imum transmittance (T1) via the relationship: 
(Are75,Fea84) 
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The T 2 value for the above band is obtained by drawing a straight line between 
-1330 and 1750cm-1. Care must be taken to choose the corresponding points on 
each of the spectra as their shapes may differ. For the 875cm-1 band, a straight 
line is drawn between the -820cm-1 and 925cm-1 points. Once the· above 
extinction coefficients are obtained, values can be calculated via the relationship: 
(Are75) 
Imperative to this study is the preparation of a series of standards of varying 
mixtures of BaC03/calcium phosphate(tribasic). From these standards a series of 
E1415/E875 values are obtained.These are then plotted against the %C03 values 
and the slope of the graph so obtained yields the %C03 value of each sample 
individually via the relationship 
%C03 = (slope*1.77)(E1415/E875) (Fea84) 
The value of 1. 77 is the slope ratio and is specific for the mixture of barium 
carbonate/calcium phosphate tribasic (CPT) used as standards in this case 
(Fea84). It functions as a conversion factor in the relationship above. 
This method has been reported as yielding an estimate of carbonate content to 
better than 10% (Fea84) . 
. ·' 
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This is proportional to the ratio of the band intensities for the co3 and P04 peaks 
(Ble75,LeGe83,Sil86).The fact that ratios are employed as opposed to absolute 
figures introduces the concept of internal standardization and overcomes the need 
for uniform and/or known particle size (Fea84). 
c] The objectives of this part of the study are: 
i) to assign the various bands in the·. spectra to their respective groups; 
ii) to determine the %C03 contents of bones and implants; and 
iii) to determine C03/P04 ratios for the above. 
2.3.1 Instrumentation and operating conditions 
In order to obtain accurate spectra, the samples were vacuum-pressed (7000psi) 
into alkali halide disks, using preheated and purified KBr. The ratio of sample to 
KBr used was 2:400mg. The spectra were recorded in triplicate in the range 
4000-400cm-1 using a PERKIN-ELMER Model 983 spectrophotometer. The 
operating conditions are given in Table 2.4: · 












In order to minimise experimental errors, a newly-pressed disk was used for each 
run. 
Before %C03 determinations were carried out, the spectra were examined and 
the major bands of importance assigned (HasX,Nel82,Pos85). These are listed in 
Tables 3.13 and 3.14, pgs.61and62. 
a] %C03 Determination: 
Six standards containing varying barium carbonate:calcium phosphate tribasic 
ratios were prepared and are listed in Table 2.5. 
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TABLE 2.5: Mass ratios of standards 
Ratio masses used %C03 
1:400 0.001 :0.3994 0.25 
1:300 0.001 :0.3001 0.33 
1:200 0.001 :0.2004 0.49 
1:100 0.001 :0.1002 0.99 
1:50 0.001 :0.0504 2.18 
1:40 0.001 :0.0404 2.72 
The reproducibility of the results was tested by preparation of two of the standards 
four times and calculating means with their respective standard deviations. An 
accuracy of 4. 75% was achieved. This is described in greater detail under· the 
section RES UL TS, p.63. 
As mentioned in the previous section, the bands at 1415cm·1 and 875cm·1 were 
examined for both the standards and the samples (implants as well as bones) 
(Fea84). Linear regression analysis was performed on the plot of E1415/E875 vs 
%C03 for the standards and the slope was calculated. This value was then used to 
calculate the respective %C03 values for all the samples via the relationship outlined 
previously (p.35). Three values were obtained for each sample (one from each 
spectrum) and the mean was taken as the final value. Thus %C03 values for the ten 
implant materials as well as the six human bone samples were obtained. 
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The C03/P04 ratios were determined· from the same spectra by making enlarged 
photocopies (three times enlargement) of the chart on which the spectra had been 
recorded. Thereafter the paper was cut along the traces defining the peaks at 1415 
and 875cm-1. Errors due to imprecise cutting were minimized by using enlarged 
spectra. These peak "cut-outs" were then weighed to yield integrated peak 
intensities. The ratio of the masses was taken as the ratio C03:P04. The 
procedure was repeated in triplicate. 
• 
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2.4 THERMAL DECOMPOSITION 
When a sample of apatite is heated, changes in its physico-chemical nature may 
occur, depending upon the rate of heating and the temperature attained 
~ 
(Cor74,Aok77,LeGe78,Bar84,Fow86). The particular temperatures at which the 
mass changes occur indicate the nature of the substance present and the extents 
of the changes indicate the amounts present (Rod85). These changes may include 
the conversion of a small percentage of the main crystal phase to another phase 
(e.g. traces of ,8-tricalcium phosphate have been reported after heating) (Aok77). 
Other changes may also include mass-losses due to liberation of water, which 
generally occurs at an early stage of heating (40 to 140°C)(LeGe78). Further 
changes which have been detected after heating are loss of protein or organic 
component (at -350°C) and loss of carbonate (at -sso-aoo°C) (Aok77, LeGe78, 
Bar84). Samples that have been investigated in this manner include human bone, 
enamel, dentine, gallstone, urinary and salivary calculi, all of which have an 
apatitic nature (Cor74, Hol80, Bar84). 
The objectives of this part of the study are: 
i) to investigate mass losses after heating; 
ii) to investigate changes in crystal phase after heating; 
iii) to investigate changes in crystal dimensions after heating;and 




The samples were ground to a uniform fine powder (mesh size 54µ m) prior to 
heating. A furnace (THERMO-ACTIVE, Model ALPHA-TWO) with variable rate 
heating capacity was used. The temperature range covered was from ambient to 
900°C and the heating rate was maintained at 10°c min-1. Approximately 0.30g of 
each sample was used in every determination. Each sample was placed in a small 
porcelain crucible and heated individually. Heating took place in three stages: 
i) from room temperature to 200°c 
ii) from 200 to 650°C, and 
ii) from 650 to 900° 
Samples were weighed at 200°c, 650°C and 900°C and were subjected to XRD 
analysis after the 650°C and 900°C stages. 
The XRD analyses involved similar parameters as previously described p.(17). The 
sample size used for these determinations was 0.05g. 
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2.5 SURFACE CHEMISTRY: 
For many years chemists and biochemists have attempted to decipher the 
interrelationships between blood and bone, for in this lies the key to understanding 
bone physiology and its electrolyte metabolism, and aid understanding of apatite 
implants for the role as suitable substitutes. A number of ion-binding studies have 
been performed on cartilage and bone to determine their ion-binding 
properties (Fre21a,Fre21b,Neu47, Boy50,Amp52). It has been shown that the 
mineral phase of bone (hydroxyapatite) is able to adsorb and exchange ions from 
solution in quantities which are dependent on certain factors, such as pH, 
concentration of ion, and presence of any competing ions (Fre21a,Boy50, 
Chr85,Kro86). For example, early studies on animal cartilage by Freudenberg and 
Gyorgy (Fre21a,Fre21b) showed that several ions were capable of exchanging 
with calcium in bone crystal. When more than one type of ion is present, 
competition for calcium sites occurred. During the fifties, experiments conducted by 
Boyd and Neuman confirmed these results (Boy50). Since then, many complexes 
have been adsorbed onto the mineral phase of bone in order to study the 
mechanism of bone-plasma interaction and the involvement of various enzymes 
(Neu51,Dry60,Mun77,Chr85,Kro86). 
Since the present study involves the comparison of the physicochemical properties 
of some implant materials with those of human bone, a series of experiments was 
devised in order to compare the ion-exchange capabilities in these two groups of 
samples. It was decided to focus attention on adsorption and exchanges of foreign 
ions with calcium, since the latter is the major component of apatite. Both 
exogenous Ca2 + and Na+ ions are expected to either adsorb and/or exchange 
with the Ca2 + ions on the surface of the apatite crystal in bone 
(Fre21a,Fre21b,Car46,Boy50, Amp52,Neu53,Neu58). Analysis of test samples by 
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atomic absorption after exposure to solutions of varying ionic strength would 
hopefully yield meaningful data which would permit conclusions to be drawn 
concerning the type of interaction which had occurred. For example, if Na+ is 
"adsorbed" onto apatite crystals, raised Na levels would be expected upon analysis. 
On the other hand, if Na+ "exchanges" with Ca2+ in the apatite lattice, progressively 
lower Ca levels would be expected within the samples. Similarly, if exogenous ca2+ 
is adsorbed, it would be reflected in increasing Ca levels. 
Thus, the objectives of this part of the study are to: 
i) determine whether the exogenous ions used either adsorb or 
exchange with ions in the surface of the bone and implant samples; 
ii) ascertain whether there exists a saturation concentration for each 
exogenous ion i.e. a maximum ionic concentration beyond which 
adsorption or exchange does not occur; 
iii) determine whether such a maximum is the same in bones and implants. 
2.5. 1 Methodology 
For each foreign ion studied, six portions (0.3g each) of finely ground bone and 
implant sample {54µm mesh size sieve) were placed in separate sealable 
containers. To each of the six containers was added 50ml of an aqueous solution 
of progressively increasing concentration of the particular ion under investigation. 
The pH was approximately 7. After sealing, the containers were agitated for three 
days (Fre21 a,Fre21 b, Boy50). The suspensions were then removed, filtered and 
washed thoroughly (using a vacuum pump) with deionised water. Once washed, 
the samples were dried in an oven at 40°C until constant mass was reached. 
A portion of this was used for AAS analysis. 
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· a] Details of experiments 
A total of 33 experiments were perform~d. Of these, the first twelve dealt primarily 
with developing a suitable procedure and optimising various parameters. 
Experimental details which were resolved in these preliminary studies are 
discussed below. 
1) Appropriate stirring procedure: ·during stirring, the suspension of bone 
powder was splashed against the inside roof of the container thereby 
limiting its exposure to the ionic solution; finally, gentle shaking of the 
solutions was found to be more efficient than stirring. 
2) Suitable containers: most containers which were initially tested were not air-
tight resulting in loss of water over the duration of the experiment. Various 
types of containers were tested: 
2.1 Erlenmeyer flasks covered with para-film were not suitable as 
extensive evaporation occurred. 
2.2 Plastic bottles with screw-caps were difficult to seal properly 
because there were insufficient windings on the cap. 
2.3 Glass bottles with plastic screw-caps were also unsuitable as the 
screw-caps, which were backed with a waxed cardboard layer, 
trapped fine sample powder and effectively removed it from solution. 
2.4 Screw-cap, all-plastic containers were found to give very 
satisfactory results. 
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3) Quantity of sample: trial and error experiments were conducted to establish 
sample masses that yielded detectable changes in elemental levels. The 
optimal mass was found to be 0.30g. 
4) Appropriate flame choice: interference in the elemental determinations 
occurred with the calcium line when using an air /acetylene mixture. 
This manifested itself in final values that were subdued. Subsequent 
determinations were carried out using the hotter nitrous-oxide/acetylene 
flame. 
46 
2.6 ATOMIC ABSORPTION SPECTROSCOPY 
Atomic absorption spectroscopy is the study of absorption of radiant energy by 
atoms (Rob66). As an analytical process, it includes the conversion of combined 
elements to atoms, and the absorption of radiant energy by those atoms. The 
radiant energy absorbed is in the form of very narrow spectral lines, generally in the 
visible and ultra-violet spectral regions. During its absorption, outer valence 
electrons are excited. Atomic absorption spectroscopy is used widely to detect 
elements at trace levels even in the presence of other elements at much higher 
concentrations. For some determinations, detection limits in the . parts per billion 
range are well within the capabilities of modern instruments (Lav68,Rub69). Since 
the technique relies only on the· absorption of energy by valence electrons in the 
ground state, the only types of interferences present are those of chemical and 
physical processes which inhibit the formation of ground state atoms in the flame 
(Whi66,Pin78,Fuw82). However, these can be rectified by careful choice of flame 
type. Because the intensity of the transmitted radiation can be represented by 
Beer's law, it means that the absorbance is proportional to the concentration at 
any specific wavelength for a given absorption path length (Dea75,Bar81). 
a] Optimisation 
As with ICP-AEs,· it is imperative that the instrument be properly aligned to acquire 
consistent, reliable data. The following parameters have to be optimised 
(Rub69,Kno84): 
(i) Lamp Operation: 
Hollow cathode lamps are used for the determinations. The lamp must be 
operated at the prescribed (manufacturer) current. If the signal-to-noise ratio is 
/ 
( ' I , 
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high, the lamp current should be increased. However, caution must be exercised, 
since increasing the lamp current increases the curvature of the calibration line. 
ii) Spray Chamber Assembly: 
The spray chamber is designed to ens,ure uniform mixing of the fuel, support and 
~ample. The flow, rates and ,flame stoichiometry h~ve to be optimized in order to 
achieve maximum precision and reliability. Of importance are the following 
(Rub69,Loo80): 
a] the nebulizer must perform optimally and in a constant manner; 
b] the optimum position of the impact bead relative to the nebulizer orifice has 
to be ascertained; 
c] the, system ~hould be flushed with water regularly to avoid contamination of 
samples in the spray chamber; 
d] the burner must be kept clear) to ensure, a steady flame. This can be 
achieved by using a mildly abrasive detergent. , 
To obtain maximum sensiti~ity and accuracy, and to keep interference to a 
minimum, the burner height and degree of rotation (lateral position) must be set 
optimally for each element combination tested. The lateral position of the burner 
must be set for maximum sensitivity, to prevent severe chemical interference 
and instability , as a result of the lower temperatures occurring at the edges of the 
flame. Sometimes the burner can be rotated from the longitudinal position as a 
convenient means of reducing sensithtity without actually diluting the sample. 
b] Flames and Gases 
Use of the correct flame type Js ,imperative to maintain ~c~ur~cy and to avoid 
interference problems. Among the many flame types, only one is relevant to the 
--------------------~-----------
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present work, namely nitrous oxide/acetylene. This flame has a higher 
temperature (3200K) than the conventional air-acetylene type (2600K) and 
possesses a strongly reducing character which permits a large range of elements 
to be determined (Lav68,Kno84). Because of the higher flame temperature, a 
special nitrous oxide burner has to be used which has a head of slightly smaller 
size than the standard air/ acetylene burner. 
c] Wavelength Selection 
In the process of selecting a suitable wavelength, the following factors have to be 
considered: 
i) sensitivity must be sufficiently high to avoid excessive sample dilution; 
ii) the intensity of the line should yield a reasonable signal-to-noise ratio; 
iii) the wavelength should be above 220nm to minimise atomic absorption by 
gases and matrix (Dea75). 
d] Interferences (Kno84): 
Two types are commonly encountered: 
i) matrix effects are often caused by precipitation of the element of interest and 
influences the amount of sample reaching the flame. To avoid this, it is 
necessary that the physical properties of sample and standard be matched 
as closely as possible; 
ii) chemical interferences occur when incomplete dissociation of compounds 
takes place, resulting in the formation of refractory compounds (such as 
calcium phosphate). This can be overcome with the use of a higher-
temperature flame such as nitrous-oxide/acetylene. 
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e] Advantages of flame AAS 
Some of the advantages include: 
i) the technique has a long history and methods for different element-
analyses are well-documented; 
ii) most elements can be easily atomized by an appropriate flame; 
iii) the instrument is easily optimized and choice of flames, although 
' 
important to the success of the analysis, is not a complicated procedure; 
iv) good sensitivity and precision (0.4-2.0% RSD) can be obtained; and 
v) the technique is simple and reliable; 
f] Instrument description and operating conditions 
The apparatus used in this study was a VARIAN-TECHTRON, Model 70. The 
various parameters used are listed in Table 2.6 while the wavelengths selected are 
given in Table 2.7. 










Lamp currentSensitivity Det.Limit 




















For all determinations, a nitrous-oxide flame was used to prevent enhancement of 
readings (5 to 10% in the case of calcium) caused by metals such as Na, K, and 
Mg. The use of a lean flame further reduced these effects. No significant 
interferences were apparent when using this flame with Na and Mg and thus, there 
was no need to change to the air/ acetylene flame for these -analyses. 
2.6.1 Methodology 
Dilutions were made by pouring each of. the dissolved sample solutions prepared 
for AAS into a separate 50ml volumetric flask and diluting with 18mohm water. A 1ml 
aliquot of each of these was placed separately into a 50ml volumetric flask and 
again made up to volume with 18mohm water. These were then used for the 
analyses. 
a] Preparation of Standards 
Standards were prepared from stock solutions (1000mg/1). Five standards 
were made for each element. The most concentrated standard for calcium was 
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5.0mg/I, beyond which an increase in curvature of the calibration line became 
apparent. 
The various concentration ranges covered by the standards are given in Table 2.8. 



















Linear regression analysis was performed on 'the readings of all standards in 
order to obtain a best line fit. An international bone standard IAEA-H5 (International 
Atomic Energy Agency, Vienna, Austria) was used in each determination to monitor 
accuracy (Bar81, Lee83a, Wan86). 
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3. RESULTS 
3.1 X-RAY DIFFRACTION 
The crystal phase present in the implant materials as well as the bone samples 
was identified as hydroxyapatite using published mineral diffraction data (Joi72). No 
trace of P-tricalcium phosphate (whitlockite) was detected in any of the samples. 
Typical XRD scans and listings of d-spacings vs intensity values for the implant 
materials and human bones are given in APPENDIX 1. 
Unit cell parameters of the implant materials are given in Table 3.1, whereas those 
of the human bone samples are given in Table 3.2. 
TABLE 3.1 : Unit-cell parameters of the implant materials 
Implant a-axis(A) S.D. c-axis(A) 5.0. 
1 9.45 .,; 6.89 
2 9.45 0.021 I 6.88 
3 9.44 6.90 
4 9.49 6.89 0.024 
,5 9.49 6.88 
6 9.45 0.014 6.90 0.048 
7 9.42 6.89 
8 9.43 0.014 6.89 
9 9.42 0.028 6.88 . 
10 9.42 6.89 
~ 
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TABLE 3.2: Unit cell parameters of the human bones 
Sample a-axis(A) S.D. · c-axis(A) S.D. 
1 9.45 6.86 
2 9.45 6.87 0.014 
3 9.45 6.87 0.014 
4 9.45 6.86 
5 9.38 6.86 0.014 
6 9.42 6.87 0.028 
Crystallinity values (calculated from the 002 reflections as described on p.19) for the 
implants as well as for the bones are given in Tables 3.3 and 3.4 respectively. 
<J> . . 
TABLE 3.3 : Crystallinity values for the implants 
Implant Crystallinity S.D. 
1 0.34 0.056 
2 0.46 0.014 
3 0.43 0.007 
4 0.35 0.009 
5 0.48 0.007 
6 0.58 0.007 
7 0.39 0.021 
8 0.51 0.007 
9 0.44 0.021 
10 0.45 0.007 
Units for the crystallinity values are 0 2e. 
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TABLE 3.4 : Crystallinity values for the human bones 
® 
Sample · Crystallinity S.D. 
1 0.41 0.007 
2 0.46 0.028 
3 0.48 0.007 
4 0.43 
5 0.46 0.007 
6 0.45 0.014 




a) %Mass content 
The mass of each implant material used for the ICP analyses is quoted in 
Appendix 2. The percentage mass content of the implants were calculated from the 
concentration values obtained from ICP data and are given in Table 3.5. 
TABLE 3.5 : %Mass contents of implants 
Sample %Ca %Mg %P %Na %Sr %K %Fe %Zn 
38.92 0.505 18.55 0.53 8.59*10-3 0.47 2.02*10-3 5.05*104 
(0.32) (0.035) (0.05) (0.005 (1.55*104 ) (0.009) (2.11*104) (6.06*10-S) 
2 37.29 18.49 1.61 1.01 *10-3 0.36 1.01 *1o-3 5.04*104 
(0.19) (0.11) (0.003) (1.21*104 ) (0.068) (2.11*104 ) (1.16*10-5) 
3 34.31 5.04*104 19.10 1.80 .. 0.34 5.04*10-4 1.51*10-3 
(0.50) (0.0025) (0.07) (0.02) (-) (0.017) (1.05*104 ) (3.53*1 o-5) 
4 33.53 0.727 20.72 0.89 0.01 0.46 0.025 
(0.28) (0.009) (0.11) (0.02) (3.88*10-3) (0.034) (-) (6.01*10-5) 
5 36.53 0.492 19.67 0.55 0.01 0.40 0.014 
(0.44) (0.003) (0.11) (0.005) (1.51*10-3) (0.045) (-) (3.53*104 ) 
6 35.49 0.315 18.66 0.54 9.63*10-3 0.37 1.01*10-3 0.033 
(0.21) (0.003) (0.09) (0.002) (2.59*104 ) (0.052) (2.68*104 ) 6.08*10-5 
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7 ~7.22 0.0015 18'91 O.d2 O.Ol 0.33, 
(0.35) (0.0015) (0.07) {0.001) {4.45*10-3) {0.002) (-) (-) 
8 39.58 2.00•10-3 19.44 ' 0.03 0.01 0.35 
(0.15) (3.5*10-3) (0.05) (0.001) {1.82*104 ) (0.006) (-) (-) 
9 38.11 0.088. 18.71 0.19 0.45 0.30 
{0.26) (1.0•1 o-3) (0.05) (2.0*10-3) (0.089) (0.052) (-) (-) 
10 38.81 0.078 18.69 0.13 0.50 0.41 
(0.11) (7.56*104 ) (0.14) (7.50* 104 ) (0.01,2) {0.05) (·) (-) 
b) Ca/P and Mg/Ca ratios 
These were calculated for·both implants and bones and are given in Tables··s.6 
. r-
and 3. 7 respectively. For the· latter, values were calculated from the final average 
values of the %mass contents given on p.60. 
TABLE 3.6: Ca/P and Mg/Ca ratios of implant materials 
I 
Implant Ca/P S.D. Mg/Ca 
1 2.10 0.006 0.013 
2 2.01 0.010 
3 1.79 0.012 1.46x1o-S 
4 1.62 0.006 0.022 
5 1.86 0.010 0.015 
6 1.90 0.012 a.a7.x10-3 
7 1.96 0.006 4.06x10-5 
8 2.03 0.006 5.05x10-5 
9 2.03 0.006 2.31x10-3 






Table 3 .6:: Ca/P and Mg/Ca mo!l:ar ·rat1!os of. implant materials · 
Implant ··•. · · Ca/P · S ;·D·· · · · Mg/Ca s .ff .. 
-------~~---~~----~--~-~~-~----~-~----~--------~----r-~---~----
1 1.63 o .001 o .. 021 
2 1.58 0 .005. 
3 1.38 0.011 '2.41*10(-5) 
4 1.27 0.008 0.036 3.5*10(-4) 
5 1. 46 0.009 0.014 
6 1. 50 0.010 0.014 2. 5*10 (-4) 
7 1.51 0;005 s . 6 8* 1 o < - 5 > 
8 1.59 0.007 8.40*10(-5) 
9 1.63 0.012 3.68*10(-3) 1 . 60* 10 (- 4) 
10 1.59 0.010 3 . 2 5* 10 ( - 3 ) 1. 70*10 (-5) 
----------------------------------------------------------------
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TABLE 3.7: Ca/P and Mg/Ca ratios for the bones 
Rx Ca/P S.D. Mg/Ca S.D. 
1. 2.71 0.035 0.013 0.004 
2. 2.22 0.071 0.012 0.003 
3. 2.29 0.007 0.012 0.001 
4. 2.22 0.042 0.016 0.007 
5. 2.18 0.042 0.008 
6. 2.20 0.014 0.009 
3.2.2 Bones 
a] %Mass contents 
The %mass contents of the six bone samples as determined by ICP are given in 
Tables 3.8 to 3.11. The masses used for the analyses are listed in APPENDIX 2. 
Two sites on each bone sample were analysed and these were done in duplicate. 
(5/"""J.J 
Table 3.7 : Ca/P and Mg/Ca molar· ratios of the bones 
-------------------------~~----------------------------
































TABLE 3.10: %Mass contents (site 2.anal 1) 
Rx %Ca %Mg %P %Na %Sr %K %Fe %Zn 
1. 25.03 (0.15) 0.246(0.021) 11. 54 (0. 048) 0.440(-) -3 -5 0.044(-) -4 1.22x10 (2.10x10 ) 0.44 (6.14x10 ) 0.0019 
2. 25.13(0.09) 0.277(0.028) 11.35 (0 .07) 0.509(-) -3 -5 0 .033 (0 .007) 0 .028 (3. 78x10-4) 2 .56x10 (1 .35x10 ) 0.0008 
3. 22.57 (0.18) 0.254(0.015) 9.73(0.01) 0.495(-) -3 -5 0.064(0.C07) -3 -4 3.95x10 (1.59x10 ) 6.21x10 (1.97x10 ) 0.0056 
4. 23.48(0.22) 0.684(0.021) 10.79(0.05) 0.647(0.011) -3 0.099(0.007) 1.52x10 (-) .023 (-) 0.0055 
5. 22.64 (0.12) 0.174 (0.033) 10.55(0.03) 0.538(0.004) -3 -4 (-) -4 1.74x10 (1.21x10 ) - 0.024(6.54x10 ) 0.0050 
6. 23.36(0.14) 0.202(0.027) 10.43(0.02) 0.504(0.008) -3 1.61x10 (-) 0.108(0.014) -4 0.036(8.48x10 ) 0.0006 
TABLE 3.11 : %Mass contents (site 2.anal 2) 
Rx %Ca %Wj %P %Na %Sr %K %Fe %Zn 
1. 23.48 (0.27) 0.246 (-) 11.05 (0.04) 0.487(0.019) 
-4 0.004(1.21x10 ) 0.051 (0.002) -4 0.039(9.21x10 ) 0.0005 
2. 23.46 (0.18) 0.265(-) 10.97(0.06) 0.620(0.012) 0.005(-) 0.021 (-) -4 0.026(5.67x10 ) 0.0024 
3. 21.50(0.20) 0.254(-) 9.42 (0.03) 0.636(0.006) 
-4 0.006(1 .97x10 ) 0.052(0.003) -4 0.005(1.94x10 ) 0.0060 
4. 22. 72 (0. 27) 0.303(-) 10.26(0.08) 0.523(0.009) 
-4 0.004(5.31x10 ) 0.089(0.007) -4 0.019(5.32x10 ) 0.0059 
5. 23.08(0.44) 0.218 (-) 10.12 (0.05) 0.539(0.003) 
. -4 
0.004 (3.51x10 ) 0.010 (-) -4 0.022(8.37x10 ) 0.0089 
6. 22.15(0.58) 0.202(-) 10.19(0.04) 0.489(0.008) 0 .004 (-) 0.110(0.021) 
-4 0.036(8.48x10 ) 0.0010 
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TABLE 3.8: %Mass contents (site 1.anal 1) 
%Ca %Mg %P %Na %Sr %K %Fe %zn 
1. 22.03(0.28) 0.28~(-) 10.05(0.02) 0.440(0.012) 9.98x10-3 (3.86x10-4) 0.194 (0.034) -3 0.065(2.73x10 ) 0.0006 
2. 22.35(0.28) 0.317(-) 10.13(0.03) 0 .532 (0 .006 ) 
-3 . -4 
4.59x10 (1.98x10 ) 0.191 (0.016) -3 0.032(1.23x10 ) 0.0002 
3. 22.18 (0.31) 0.310(-) 9.76(0.04) 0 .561 (0 .005) -3 -4 5.53x10 (1 .55x10 ) 0.091 (0.028) -4 0.038(8.85x10 ) 0.0074 
4. 18.48(0.17) 0 .198 (-) 8.43(0.02) 0.328(0.005) -3 -5 2.34x10 (2.15x10 ) 0.098(0.026) -4 0.033(9.19x10 ) 0.0002 
5. 18.72(0.27) 0.153(-) 8.96 (0.03) 0.337(0.003) -3 2.62x10 (-) 0.068(0.031) -3 0.078 (1.33x10 ) 0.0005 
6. 21.11(0.56) 0.200(-) 9.97(0.02) 0.369(0.002) -3 3.14x10 (-) 0.163(0.072) -3 0 .058 (1.03x10 ) 0.0001 
TABLE 3.9: %Mass contents (site 1.anal 2) 
-----------·· ·------·-· 
Rx %Ca %Vi:J %P %Na %Sr %K %Fe %Zn 
1. 23.14 (1.58) 0.301 (0.08) 10.65(0.92) 0.406(-) 
-4 0.008(1.22x10 ) 0.119(0.099) 0.048(0.00B) 8x10-4 (6x10-5) 
.2. 23.54 (1.06) 0.282(0.05) 10.62(0.78) 0.571 (0.008) -4 0.005(1.51x10 ) 0.109 (0.116) 0.027(1x10-4) 0.0011 (Bx10-
4) 
3. 22.08(0.05) 0.282(0.04) 9.62(0.06) 0.579(0.018) 
-5 0.006(1.83x10 ) 0.076(0.026) 0.024 (0.011) 0.0048(0.0015) 
4. 20.96 (3.03) 0.351 (0.20) 9.44(1.54) 0.461 (0.176) 
-4 0.003(2.18x10 ) 0.098(0.005) 0 .017 (0 .005) 0.0049(5x10-4) 
5. 20.99(2.64) 0.175(0.03) 9.61 (1.03) 0.442(0.134) 
-4 0.003 (1.54x10 ) 0.036(0.044) 0.043(0.018) 0.0050(-) 
6. 22.16(0.86) 0.201 (-) 10.07(0.34) 0.449(0.068) 
-4 0.004(1.21x10 ) 0.137(0.039) 0.042(0.008) 6x10-4 (4x10-4) 
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TABLE 3.12: Ave. of %mass contents of site 1 and site 2 
Rx %ca %M %P %Na %Sr %K %Fe %Zn 
1; 22.00(0.48) 0.420(0.022) 9.95(0.03) 
-3 0.372 (8.86x10 ) 0 .185 (0 .028) 0.185(0.028) -4 0.042(6.40x10 ) 0.0002 
2. 23.23(0.07) 0.317(0.025) 9.99(0.04) 0.622(0.007) 
-5 0.007(1.51x10 ) 0.190(0.017) -4 0.019(3.53x10 ) 0.0008 
3. 22.03(0.03) 0.310(-) 9.56(0.03) 0.620(0.008) o.008 H 0.097(0.031) 
-4 0.026(5.53x10 ) 0.0019 
4. 19 .16 (0 .11) 0.216(-) 8.26(0.02) 0.343(0.006) 
-4 0.004 (1.26x10 ) 0.104 (0.018) -4 0.021 (3.60x10 ) 0.0090 
5. 19.51 (0.09) 0.153 (-) 8.80(0.02) 0.351 (0.003) 0.004(-) 0.066(0.036) 
-3 0.046(1.07x10 ) 0.0036 
6. 22.00 (0.13) 0.200(-) 9.68(0.02) 0.432(0.003) 
-5 0.005(1.07x10 ) 0.164 (0.068) -4 0.036(5.71x10 ) 0.0005 
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3.3 INFRARED SPECTROSCOPY 
3.3.1 Frequency assignments 
The frequency assignments for the implant materials and the bone samples are 
given in Tables 3.13 and 3.14 respectively. 
Typical IA spectra for implants and bones_are included in APPENDIX 3. 
TABLE 3.13 : Freguenc~ assignments for the imglants (cm-1) 
(!) ~,.(Ip_ (\ e x.J- fA~('. 
Vihratinq qp. Mode S1 S2 SJ S4 SS S6 S7 SB S9 S10 
()fl 3422 3431 3418 3424 3416 3422 3426 3421 3433 3429 
1625 1631 1640 1645 1614 1658 1635 1631 1644 1640 
P04 v2 1089 1088 1087 1088 1089 1088 1088 1089 1087 1087 
1043 1039 1037 1042 1041 1040 1042 1037 1040 1041 
v4 631 630 628 630 629 630 628 630 630 628 
602 601 601 601 602 602 600 601 601 601 
568 566 566 569 567 567 569 567 567 567 
mJ v2 960 958 961 960 962 961 960 961 961 961 
V3 1458 1459 1459 1459 1459 1458 1460 1457 1459 1459 
® 
f,,-eCftvq_v-c.~1 a~c;.~~"'""e~~~ fciv- ,'...,._11)l"'""~~ t'-""'-') 
-----------------------------------------------------------------
Vibrating Mode Sl S2 S3 S4 S5 S6 
gp. 
----------------------------~------------------------------------
OH 3422 3431 3418 3416 3416 3422 
631 630 628 630 629 630 
OH<H20) 1625 1631 1640 1645 1644 1658 
P04 vl 960 958 961 960 962 961 
v2 1089 1088 1087 1088 1089 1088 
1043 1039 1037 1042 1041 1040 
v4 602 601 601 601 602 602 
568 566 566 569 567 567 
C03 v2 871 870 871 871 872 870 
v3 1458 1459 1459 1459 1459 1458 
1412 1415 1418 1413 1415 1415 
----------------------------------~----------~--------------------
-----------------------------------------------~---------
Vibrating Mode S7 S8 SS SlO 
gp. 
---------------------------------------------------------
OH 3426 3421 3433 3429 
628 ·630 630 628 
0H(H20) 1635 1631~ 1644 1640 
P04 vl 960 961 961 961 
v2 1088 1089 1087 1087 
1042 1037 1040 1041 
v4 600 601 601 601 
569 567 567 567 
C03 v2 872 871 871 871 
v3 1460 1457 1459 1459 
1417' 1415 1415 1415 
---------------------------------------------------------
62 
TABLE 3.14: Frequency assignments for the human bones (cm-1) 
Vibrating gp. Mode 81 82 83 84 SS 86 
OH 3567 3566 3566 3568 3394 3418 
P04 v1 960 960 960 960 960 960 
v2 1088 1088 
1040 1033 1029 1029 1037 1040 
V4 632 629 629 631 
601 602 601 601 602 602 
569 564 564 569 567 567 
875 871 878 891 871 871 
1457 1459 1459 1460 1457 1459 
3.3.2 %C03 Values 





Sl S2 83 S4 S5 S6 
-----------------------------------------------------------------OH 3567 3566 3566 3568 3394 3418 
~ ·. ' 
-~--··--- ---- ·---
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TABLE 3.15 : Average 8 values for standards 
Standard ave./3 
1 0.25 3.04 
2 0.33 3.29 
3 0.49 3.49 
4 0.99 3.53 
5 2.18 4.51 
6 2.72 4.54 
In order to check the reproducibility of these values, the entire procedure 
involving . pellet pressing and infrared scanning was . repeated four times for 
standards 2 and 5. The average values are given in Table 3.16. 













There is thus a percentage relative standard deviation of 4-5% associated with this 
method. 
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The slope of the calibration curve of %C03 vs f3 is 0.5938. 
@ 
'9-Values and their corresponding %C03 figures for the ten implant materials are 
given in Table 3.17, while those for the human bone samples are given in Table 
3.18. 











Due ·to the 
sufficient to 
value of the 
of carbonate 
samples. 
2 3 %C03%C03 %C03 ave.%C03 S.O. 
2.26 1.83 2.50 2.37 1.92 2.62 2.30 0.35 
2.49 2.10 2.03 2.62 2.21 2.13 2.32 0.26 
0.55 0.40 0.45 0.57 0.42 0.47 2.49 0.18 
3.45 3.05 3.51 3.63 3.21 3.69 3.51 0.26 
2.73 2.67 2.62 2.87 2.81 2.46 2.71 0.22 
2.86 3.11 3.15 3.01 3.26 3.31 3.19 0.16 
2.46 2.33 2.59 2.58 2.34 2.72 2.55 0.19 
1.52 1.80 1.75 1.59 1.89 1.84 1.77 0.16 
1.76 1.70 2.05 1.85 1.70 2.15 1.90 0.23 
2.01 1.97 2.33 2.11 2.07 2.45 2.21 0.21 
linearity of the ·calibration curve, it was deemed 
extend the %C03 range to the value of 2.72, since the 
slope obtained would be accurate enough even for values 
content up to the maximum of 6% obtained for some 
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TABLE 3.18 : List of 8. %C03 and ave. %C03 values of bones 
Sample 2 3 %C03 %C03 %C03 ave. %C03 S.D .. 
4.95 4.50 4.91 5.20 . 4.73 5.16 5.03 0.26 
2 4.07 4.33 4.61 4.91 4.55 4.84 4.77 0.19 
3 3.98 4.59 4.14 4.18 4.82 4.35 4.45. 0.33 
4 5.25 5.05 5.65 5.52 5.31 5.94 5.32 0.31 
5 5.56 5.01 5.42 5.84 5.26 5.69 5.33 0.29 
6 3.82 3.95. 3.75 4.01 4.15 3.94 3.84 0.16 
The C03/P04 ratios . for the ten implant materials as calculated from the spectra 
are given in Table 3.19, while those for the human bone samples are given in 
Table 3.20. 
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TABLE 3.19: C03/P04 ratios of the implant materials 
Implant S.D. 
1 0.338 0.093 
2 0.333 0.111 
3 0.328 0.070 
4 0.295 0.058 
5 0.285 0.053 
6 0.267 0.021 
7 0.353 0.078 
8 0.271 0.065 
9 0.209 0.048 
10 0.254 0.041 
TABLE 3.20: C03/P04 ratios of the bones 
Sample S.D. 
1 0.310 0.010 
2 0.311 0.011 
3 0.349 0.020 
4 0.309 0.015 
5 0.318 0.035 
6 0.287 0.013 
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3.4 THERMAL DECOMPOSITION 
3.4.1 Mass losses 
The total mass-loss incurred by each sample after heating to 900°C, is recorded in 
Table 3.21. 
TABLE 3.21 : Total %mass-loss for each sample tested 
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3.4.2 XRD analysis 
Unit cell parameters,crystallinity and crystal phase identification data for implants 
and bone samples during heating are given in Tables 3.22 to 3.25. 
TABLE 3.22: XRD parameters of implants - after heating to 650°C 
Implant a-(A) S.D. c-(A) S.D. crystallinity S.D.- crystal phase 
1 9.42 0.0146 6.90 0.014 0.29 0.007 HA 
2 9.42 0.007 6.89 0.33 0.009 HA 
3 9.42 6.90 0.28 0.007 HA 
4· 9.44 0.028 6.90 0.24 0.007 HA 
5 9.42 0.007 6.91 0.028 0.45 0.014 HA 
6 9.42 6.89 0.50 0.007 HA 
7 9.39 0.010 6.88 0.007 0.24 0.007 HA 
8 9.42 6.90 0.23 0.021 HA 
9 9.42 6.88 0.014 0.23 0.014 HA 
10 9.42 6.89 - 0.25 ·0.014 HA 
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TABLE3.23: XRD parameters of implants - after heating to 900°C 
Implant a-(A) S.D. c-(A) S.D. crystallinity S.D. crystal phase 
1 9.44 0.014 6.86 0.25 0.007 HA 
2 9.42 0.007 6.86 0.26 0.021 HA + .B-TCP +Cao 
3 9.42 6.86 0.007 0.22 0.014 HA + .B-TCP +Cao 
4 9.42 6.86 0.20 0·.014 HA 
5 9.42 6.86 0.007 0.19 0.007 HA 
6 9.42 0.007 6.86 0.40 0.020 HA 
7 9.39 0.014 6.86 0.19 0.007 HA 
8 9.42 6.86 0.21 0.007 HA 
9 9.42 0.014 6.86 0.007 0.18 0.014 HA+ Cao 
10 9.44 6.86 0.25 0.007 HA+ CaO 
TABLE 3.24: XRD parameters of human bones- after heating to 650°C 
Sample a- (A) S.D. c-(A) S.D. crystallinity S.D. crystal phase 
1 9.45 6.88 0.45 0.014 HA 
2 9.45 6.89 0.46 0.007 HA 
3 9.45 0.007 6.90 0.007 0.43 0.014 HA 
4 9.43 6.88 0.014 0.44 0.007 HA 
5 9.40 0.014 6.88 0.44 0.007 HA 
6 9.42 0.014 6.89 0.007 0.45 0.007 HA 
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TABLE 3.25: XRD parameters of human bones - after heating to 900°C 
/ 
Sample a-(A) S.D. c-(A) S.D. crystallinity S.D. crystal phase 
1 9.46 0.007 6.90 0.007 0.31 0.007 HA+ Cao 
2 9.46 0.014 6.89 0.27 0.014 HA 
3 9.45 0.007 6.88 0.26 0.014 HA+ Cao 
4 9.44 6.89 0.014 0.28 0.007 HA+ Cao 
5 9.42 0.007 6.88 0.007 0.27 0.014 HA+ Cao 
6 9.44 0.014 6.88 0.24 0.007 HA+ Cao 
Typical XRD scans and lists of d-spacings vs intensity taken after each _heating 
stage for the implants and the bones are given in APPENDIX 4. 
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3.5 SURFACE REACTIONS (AAS RESULTS) 
Linear regression analysis was performed on the values obtained for the 
calibration curves used in every experiment. 
3.5.1 Experiment 13 
In this experiment, samples of human forearm bone (radius) were exposed to 
aqueous NaCl solutions of varying concentration (Table 3.26). The %mass contents 
for both Ca and Na were determined. 
TABLE 3.26: Ca and Na levels after exposure to NaCl solutions • 
Solution NaCl(M) %Ca S.D. %Na S.D. • 
1 0.011 20.11 0.18 0.310 0.035 
2 0.019 20.02 0.29 0.318 0.024 
3 0.100 20.08 0.31 0.330 0.017 
4 0.153 19.52 0.20 0.352 0.026 
5 0.322 18.48 0.14 0.486 0.009 
6 4.967 18.07 0.19 0.530 0.034 
3.5.2 Experiment 14 
Since the NaCl concentration range between 0. 1 and 0.322M produced the most 
notable effect in Experiment 13 (as observed by changes in the %Ca and %Na in 
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the samples), it was decided to explore the effect further by exposing the samples 
to several NaCl solutions within this range {Table 3.27). As in the previous 
experiment, the levels of Ca and Na in the samples after exposure were determined. 
, TABLE 3.27: Ca and Na levels in bone after exposure to NaCl solutions 
Solution NaCl(M) %Ca S.D. %Na S.D. 
1 0.03 19.54 0.26 0.309 0.051 
2 0.10 19.41 0.12 0.318 0.029 
3 0.15 19.28 0.36 0.348 0.015 
4 0.20 18.79 0.30 0.364 0.031 
5 0.25 18.85 0.14 0.389 0.027 
6 0.30 18.32 0.26 0.456 0.018 
7 0.40 18.38 0.27 0.504 0.030 
8 1.44 18.25 0.42 0.568 0.017 
3.5.3 Experiment 15 
Bone samples were placed in aqueous solutions of CaCl2 of varying 
concentrations {Table 3.28). Only Ca levels were determined in each 
sample after exposure. 
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TABLE 3.28: Ca levels in bone after exposure to CaCl2 solutions 
Solution CaCl2(M) Ca S.D. 
1 0.01 24.87 0.32 
2 0.05 24.21 0.15 
3 0.10 24.59 0.26 
4 0.20 24.64 0.42 
5 0.30 23.91 0.30 
6 0.51 24.26 0.18 
7 1.70 24.63 0.26 
3.5.4 Experiment 16 
Since experiment 15 appeared to indicate "saturation", it was decided to repeat the 
experiment in a lower CaCl2 concentration range {Table 3.29). 
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TABLE 3.29: Ca levels after exposure 
Solution %Ca S.D. 
1 6x10-5 21.31 0.29 
2 2x10-4 21.80 0.48 
3 6x10-4 22.89 0.32 
4 1x10-3 23.68 0.13 
5 3x10-3 24.25 0.37 
6 8x10-3 24.52 0.30 
3.5.5 Experiment 17: 
In this experiment, implant 1 was exposed to three different CaCl2 solutions and 
three different NaCl solutions. The levels of Ca and Na are given in Table 3.30. 
TABLE 3.30 : Ca and Na levels in implant 1 after exposure to CaCl2 and NaCl 
solutions 
Solution CaCl2(M) NaCl(M) %Ca S.D. %Na S.D. 
1 0.0003 37.83 0.14 0.491 0.035 
2 0.0007 37.11 0.39 0.436 0.041 
3 0.0065 37.15 0.28 0.485 0.022 
4 0.20 37.52 0.41 0.476 0.033 
5 0.40 37.77 0.28 0.423 0.028 
6 1.41 37.42 0.13 0.468 0.016 
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IAEA-H5 standard and untreated implant (i.e. implant prior to exposure to aqueous 
solution) were analysed to determine the precision of the results. The Ca and Na 
levels obtained are given in Table 3.31. 















The reference (literature) values for this standard are given in Table 3.32 (Mah83). 
TABLE 3.32: IAEA-H5 standard reference values 
%Ca S.D. %Na S.D. 
21.17 2.40 0.477 0.097 
3.5.6 Experiment 18 · 
In this experiment, implant 2 was treated as described in Expt.17. The Ca and Na 
levels are given in Table 3.33. 
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TABLE 3.33 : Ca and Na levels in · implant 2 after exposure to CaCl2 and NaCl 
solutions 


























To monitor precision, the IAEA-H5 standard and untreated implant were also 
analysed. 
Ca and Na levels are given in Table 3.34. 
















3.5. 7 Experiment 19 
·1n this experiment implant 3 was treated as described in the previous experiments. 
TABLE 3.35 : Ca and Na levels in implant 3 after exposure to CaCl2 and 
NaCl solutions 











































3.5.8 Experiment 20: 
In this experiment, implant 4 was treated as described in ttie previous 
experiments. Table 3.37 gives the Ca and Na levels after 
exposure to CaCl2 and NaCl solutions. 
TABLE 3.37 : Ca and Na levels in implant 4 after exposure to CaCl2 and 
NaCl solutions 
Solution CaCl2(M) NaCl(M) %Ca S.D. %Na S.D. 
1 0.0003 31.79 0.35 0.629 0.019 
2 0.0007 31.51 0.18 0.678 0.028 
3 0.0065 31.42 0.19 0.691 0.025 
4 0.20 31.03 0.33 0.618 0.035 
5 0.40 31.42 0.31 0.654 o'.022 
6 1.41 31.89 -0.24 0.626 0.013 
As previously, precision was monitored by analysis of IAEA-H5 standard and 
untreated implant 4. The Ca and Na levels are given in Table 3.38. 


















Implant 5 was used in this experiment. Table 3.39 gives the Ca and Na levels 
obtained after exposure. 
TABLE 3.39 : Ca and Na levels in implant 5 after exposure to CaCl2 and NaCl 
solutions 
Solution CaC12(M) NaCl(M) %Ca S.D %Na S.D. 
1 0.0003 35.92 0.16 0.487 0.021 
2 0.0007 35.28 0.39 0.521 0.029 
3 0.0065 35.16 0.42 0.533 0.038 
4 0.20 36.05 0.25 0.499 0.037 
5 0.40 35.63 0.28 0.475 0.031 
6 1.41 35.89 0.40 0.509 0.044 



















TABLE 3.41 : Ca and Na levels in implant 6 after exposure to CaCl2 and NaCl 
solutions 








































Due to insufficient material, no experiments could be performed using implants 
7,8, and 9. 
3.5.11 Experiment 23 
This experiment involved implant 10. 
TABLE 3.43 : Ca and Na levels in implant 1 O after exposure to CaCl2 and 
NaCl solutions 
Solution CaCl2(M) NaCl(M) %Ca S.D. %Na S.D. 
1 0.0003 37.21 0.48 0.095 0.031 
2 0.0007 37.39 0.33 0.110 0.050 
3 0.0065 37.92 0.24 0.128 0.024 
4 0.20 37.11 0.29 0.085 0.039 
5 0.40 37.55 0.16 . 0.112 0.036 
6 1.41 36.98 0.34 0.108 0.029 












4.1 X-RAY DIFFRACTOMETRY 
4.1.1 Implant samples 
A] Crystal phase 
As mentioned in the RESULTS section, all the implants were found to be 
hydroxyapatite. The possible presence of /3-TCP, otherwise known as whitlockite, 
was investigated as other workers have reported its presence in lower 
concentrations alongside the hydroxyapatite phase (Sob49,Wan86). However, no 
traces of this phase were found in any of the samples. The spectra were also 
inspected for the presence of intensity enhancements due to the possible 
inclusion of calcite (Sil86,SilX). Common reflections in the calcite and 
hydroxyapatite spectra are given in Table 4.1. 




















It is seen that the presence of calcite might be detected by enhancement of 
the reflection in the apatite spectrum at a d-spacing of 3.08A. The relative 
intensities of this reflection in the ten implant samples are given in Table 4.2. 
TABLE 4.2: Intensities of reflection at d=3.08A of the implant materials 
1 2 3 4 5 6 7 8 9 10 
19.20 28.95 25.85 18.00 25.55 22.90 21.70 22.40 18.77 18.25 
Although implants 2,3 and 5 appear to show an increased intensity, caution must 
be exercised in interpreting this as being indicative of calcite inclusion as no 
mention is made in the literature of the extent to which intensity enhancement 
might be expected. Moreover, none of the samples displayed a peak at d=2.09A, 
which is exclusive to calcite (Blu75,Sil86), relative to HA. Thus, if calcite is indeed 
present in the samples mentioned, it can only be in very low quantities. 
B] Cell parameters and crystallinity 
The inorganic portion of teeth and bones is basically "impure" calcium phosphate 
occurring predominantly in crystalline form as "biological apatite" (LeGeX,You75). 
The inorganic component of bones comprises 75% of the entire structure. 
Various substitutions may take place within this structure which can be 
manifested by changes in the- lattice parameters (a- and c-axes) of the apatite 
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depending on the size of the substituting cation or anion (Tra55, Pos63, Mco65, 
LeGe69, LeGe80, Tra85). The incorporation of one such cation, n~mely 
carbonate, has been the subject of study and speculation for more than three 
decades (LeGe57,Mco60,LeGe65,LeGe67, LeGe69,LeGe83). Despite this, 
uncertainty still prevails over the mode of incorporation of carbonate into the 
apatite structure. For example, Eitel first proposed a C03-for-OH substitution in 
the apatite structure (LeGe69). In such a substitution, the planar C03 group is 
larger than the OH group and an expansion of the unit cell of the apatite would be 
expected (Meo65, LeGe69, LeGe80, LeGe81). However, LeGeros and Trautz 
(LeGe67,LeGe68) have presented evidence showing that co3 substitutes for P04 
in the apatite structure. If this is indeed the case, then such substitution would be 
accompanied by a contraction of the unit-cell, since the planar carbonate is 
smaller than the tetrahedral P04 group it replaces. This is because the 0-0 
distance in a C03 group is 15% smaller than the 0-0 distance in a regular P04 
group (LeGe67). McConnell (Mco65) also supports the theory of carbonate for 
phosphate substitution in the apatite structure of both the mineral carbonate 
apatites (e.g. Dahllite, Staffelite, and Fancolite) as well as in the calcified tissues of 
teeth and bone. According to McConnell, four flat C03 groups replace three 
tetrahedral P04 groups, so that one C03 group is located on the trigonal axis of 
the crystal, while the other three C03 groups are located vertically around the axis 
(Mco65,Tra85). This is said to occur in hexagonal structures 
(LeGe67,LeGe68,Tra85), of which all the samples tested in this study are an 
example. Furthermore, when carbonate is included in the apatite structure, a 
corresponding decrease in the amount of phosphate has been observed 
(LeGe65,LeGe67,LeGe68). This has been shown to occur even when all OH-
groups were replaced by F in the structure, rendering OH sites unavailable for 
C03 substitution (LeGe67). A recent report by LeGeros (LeGe81) presents a final 
compilation of the mode of carbonate substitution: In synthetic apatites, there can 
occur either, C03-for-OH substitution (in which case there is an expansion of the 
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a-cell parameter), or C03-for-P04 substitution, which is accompanied by cell size 
changes already discussed. The former mechanism has been observed in 
apatites obtained from non-aqueous systems (at temperatures around 1000°C), 
and the latter from aqueous systems (temperatures around 100°C) 
(LeGe69,LeGe81). In apatites of natural origin, however, it seems that C03-for-
P04 substitution is the favoured mechanism (Hir47, LeGe57, LeGe68, Blu81, 
LeGe81). 
To determine which type of substitution is prevalent in the implant materials tested 
in this work, the unit cell parameters were calculated according to the method 
outlined on p.18 of this study. Measurements determined by Elliott et al (Ell73) will 
be used as reference values. His studies were performed on Holly Springs 
· hydroxyapatite, which is considered to be "carbonate-free". These cell dimensions 
are as follows: 
a = 9.4214(8) A and 
c = 6.8814(7) A 
(The values in brackets are the standard deviations). 
These values may be compared with those obtained in the present study for the 
ten implant materials. Values of these parameters are given in Table 3.1, p.52. 
<t,plants 1 to 6 have a-cell parameters which are greater (maximum difference 
0.21%) than that of HA tested by Elliott while samples 7 to 10 lie close to the 
reference value. The c-cell parameters do not differ significantly from the 
r~ference value, and this is to be expected, since according to McConnell 
(Mco65), effects of substitutions manifest themselves more in terms of a-cell sizes 
than c-cell sizes. Perhaps then, implants 1 to 6 have a C03-for-P04 mode of 
substitution, while samples 7 to 10 favour a C03-for-OH mode of substitution. 
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In retrospect., · it may be said that the scanning speed used (2° /min) 
was perhaps somewhat too fast to ensure accurate lattice parameter and 
crystallinity measurements. 
However.this is a very tentative suggestion, since according to studies performed 
by R.Z. Le Geros et al (LeGe65,LeGe67,LeGe81), the increase in a-cell sizes can 
also be attributed to the possible presence of chlorine ions substituting for OH, as 
well as HPo/- substituting for P04
3• in these structures. These substitutions 
cause a lengthening of the a-cell parameters, overriding any shortening effects 
that may be prevalent due to C03-for-P04 substitution also present in the 
structure. 
Other substituents and their influences have been reported. These include: 
i) incorporation of fluoride substituting for OH groups causes a shrinkage in 
a-cell size, and no change inc-cell size (Pos63,Mco65,LeGe87); 
ii) cations larger than Ca2 + , such as sr2 + , Pb2 + , and Ba2 + , can be 
incorporated in the apatite structure to a greater extent than those which 
are similar or smaller in size, such as Na+, Mg2 + · and Zn2 + 
(LeGe80,LeGe84). If the cation is larger than Ca2+, then the lattice 
parameters expand after incorporation, and vice versa with the smaller 
cations. 
iii) substitution of H20-for-OH groups causes an expansion of the a-cell 
parameter. lhis incorporation may be accompanied by the substitution of · 
H40 4-for-P04, also causing an expansion in the a-cell parameter 
(Mco65,LeGe78,LeGe84). 
Unfortunately, the simultaneous or concerted substitutions of different ions in 
apatites cause additive or conflicting effects on the physico-chemical properties of 
the apatite (LeGe84). Therefore, it cannot be ascertained merely from the cell-
parameters which mode of substitution is present. 
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The question of whether any C03-for-P04 substitution occurs in the implant 
materials, can be further addressed, albeit tentatively, from the separation of the 
peak intensities of the 112 and 211 maxima (LeGe65, LeGe67,LeGe69,LeGe80). 
According to LeGeros (LeGe65,LeGe67), the higher the% mass content of C03 in 
the apatite, the less is this peak separation. Fig.4.1 shows the 112 and 211 
separations for the ten implant materials. 
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From Fig. 4. 1, it is seen that samples 4 and 7 display the most marked 
separations of the 112 and 211 peaks. Samples 5, 6 and 8 do not display such 
separations i.e. their 112 and 211 peaks have become superimposed. This 
occurs as a result of broadening of the diffraction maxima, (i.e. a decrease in 
degree of crystallinity) which could be caused by the presence of carbonate 
(Sob49,Mco65,LGe68,LeGe80,Blu81,LeGe81). Both McConnell (Mco65) and 
LeGeros (LeGe68) state that once col- is incorporated, the degree of 
crystallinity of the sample decreases. Therefore, the higher the suspected 
carbonate content of a sample, the lower will be its relative degree of crystallinity. 
Accordingly, implants 5, 6 and 8 are expected to have the highest carbonate 
content which would be reflected by their relatively low crystallinity values. On the 
other hand, implants 1, 4 and 7 (all of which displayed marked separations of the 
112 and 211 reflections) are expected to have the lowest carbonate content 
which would be reflected by relatively high crystallinity values. Inspection of Table 
3.3, p.53, indicates that the results of the present study confirm this prediction. It 
is seen that samples 1,4 and 7 do indeed display relatively small peak widths 
(0.34, 0.35 and 0.39 respectively) indicating a high degree of crystallinity, while 
samples 5,6 and 8 display relatively large peak widths (0.48, 0.58 and 0.51 
respectively) indicating a low degree of crystallinity. 
The other implant samples are in an intermediate range, as expected. It seems 
that on a · relative basis, the samples differ with respect to their degree of 
crystallinity, and that this might be attributed to possible differences in carbonate 
contents. However, carbonate is only one of the many substituents which can 
influence the crystallinity of a sample. For example, the presence of magnesium, 
potassium or fluoride can have conflicting influences upon the crystallinity of the 
apatite, depending upon the quantity incorporated (LeGe84). Thus, a correlation 
between the crystallinity values obtained by the above technique and %C03 
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values obtained from infrared data could lead to a meaningful conclusion. This will 
be discussed later in this chapter (p.104). 
4.1.2 Bone samples 
A] Crystal phase 
As with the implant materials, the bone samples were found to be hydroxyapatite. 
According to Hirschman et al (Hir47), bone containing normal levels of P04 have 
HA as the main crystal phase present, with no traces of ,8-TCP. The spectra of the 
present study were inspected in the 2 region around 31,35 and 37 degrees, 
where ,8-TCP gives rise to high intensity peaks (100, 55 and 25% respectively) 
(Joi72,LeGe81). However, no ,8-TCP was detected. the spectra were also 
examined for Cao since this substance has been previously identified in bone 
(LeGe81,Sil86). Indeed, a peak at d=2.34A was found in each of the bone 
samples, their intensities varying around the 10% value, thus suggesting traces of 
Cao in the bone samples. 
Finally, an investigation for the presence of CaC03 was performed as for the 
implant materials. The intensity of the peak at d =3.08A was studied (Table 4.3). 
TABLE 4.3 : List of intensity at d =3.08A of bone samples 
1 2 3 4 5 6 
22.13 23.23 22.64 26.62 25.33 20.71 
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The enhanced intensities would suggest that CaC03 might be present, but as with 
the implants, no trace of a peak at d=2.09 (which is exclusive to calcite) was 
detectable. Hence, only very low quantities of CaC03 can be expected in these 
bone samples, if at all. 
B] Cell parameters and crystallinity 
The cell parameters of the six bone samples were calculated usin,g th~ same 
relationships as those for the implant materials and are listed in Table 3.2,p.53. 
Comparison of these values to those of "pure" HA, shows that the a-cell 
parameters are larger in the bone samples. This may be attributed to C03-for-OH 
substitution or otherwise a C03-for-P04 substitution (shortening of a-axis) is being 
masked by the effects of "lattice H20" present, Cl-for-OH an~ other concerted 
substitutions of larger cations (LeGe78,LeGe81). 
c-Cell parameters in some of the bones are slightly smaller than that of Holly 
Springs HA (Mac72,Ell73). However, both C03-for-OH substitution and the 
concerted substitutions which may accompany a C03-for-P04 substitution cause 
c-cell parameter reduction, so that again, no conclusion can be made as to which 
mode is favoured here. 
Crystallinity values, (Table 3.4, p.54), show that the bones displayed lower 
degrees of crystallinity (i.e. broader peak-widths of 002 reflection) than the implant 
materials. Closer examination reveals that samples 1 and 4 have the narrowest 
002 peak widths, indicating highest crystallinty relative to the other bone samples. 
Yet, even though these are the narrowest peak widths found among the bones, 
the narrowest values found for the implants were in the region of 0.35 °20 . This is 
expected, as results reported by LeGeros (LeGe81) noted the tendency of bone 
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to display very much broader peaks than those displayed by apatite in enamel or 
dentine. As before, this can be substantiated by addressing the peak separation 
between the 112 and 211 reflections. Fig.4.2 presents the relevant peaks for each 
sample. 










From these spectra it can be seen that only samples 1 and 4 display small 
shoulders on the 211 peaks due to the 112 reflections. The other samples have 
no trace of a peak due to 112 reflection at all. If the principles of C03 contents, 
already outlined in the discussion of the implant materials, are applied, then it 
would seem that samples 1 and 4 have slightly lower C03 content than that of the 
others. Generally, however, the peaks of the bone samples seem to be slightly 
broader and less separated than those of the implant materials, which would 
confirm a lower degree of crystallinity for the bone samples. Whether this could 
indeed be attributed to a higher content of C03 or not, will perhaps become more 
apparent when the results of the infra-red studies are considered. 
4.1.3 Summary 
It seems as if both the implants and the bone samples are composed of 
hydroxyapatite crystals, with the difference being that the bones have trace 
amounts of Cao present. In both groups of samples, no trace of calcite appears 
to be present. When compared to Holly Springs hydroxyapatite, the a-cell 
parameters of some of the implants were found to be 0.21% greater. However, 
only bone sample number 4 had its a-cell parameter equal to that of Holly Springs 
apatite; the remainder all displayed slightly increased a-cell sizes. It appears that 
the c-cell parameters of implants and bones are similar to those of the reference 
material. Because the manifested changes in a-cell sizes of most implants and 
bones are not very great, it is assumed that if any impurities are present, they 
occur in very small quantities. 
Generally, the relative degree of crystallinity of the implant materials was found to 
be higher than that of the bones, reflecting a decreased crystallite size and/or 
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increased crystallite strain for the bone (leGe81), partly attributable perhaps, to a 
higher C03 content in the latter. 
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4.21CP 
4.2.1 Implant materials 
In natural hydroxyapatite, the Ca/P ratio has been found to be 1.67 
(Mco65,Sil86). Any departure from this value may be assigned to substitutions 
occurring, amongst others, for either Ca or P04 in the structure. For example, if 
there is C03 substituting for P04, the ratio will increase. On the other hand, if 
there are ions such as Na+ or Mg2 + substituting for Ca2 +, then the ratio will 
decrease. The Ca/P ratios can then be compared with powder diffraction results, 
since crystallinity may be regarded as an indication of the extent of C03 in the 
structure. 
Consideration of the Ca/P ratios for the implants in the present study (Table 3.6, 
p.56), reveals that only sample 4 has a value below that of hydroxyapatite. While 
this may be due to C03 substituting for P04, other substitutions might explain this. 
For example, Table3.5, p.55 shows that sample 4 has the highest level of Mg2+, 
and a relatively high level of Na+. Thus, these elements may be substituted for 
some of the Ca2 + in the crystal, thereby decreasing the Ca/P ratio of the sample. 
Implant number 3 has a Ca/P ratio (1. 79 .±. 0.03) which is below the average for 
all the samples (1.94 .±. 0.14). Although the Mg level in this implant is relatively 
low (5.04x104 .±. 0.0025%), the value for Na (1.80 .±. 0.017%) is the highest of all. 
Thus implant 3 might be exhibiting a greater extent of Na-for-Ca substitution than 
the other implants, thereby reducing the Ca/P ratio below the average. However, 
C03-for-P04 substitution might well be present, as in implant 4, which would 
explain its inflated Ca/P ratio relative to natural hydroxyapatite. 
95 
The remainder of the implants have Ca/P ratios which are similar to each other. 
These values are above 1.67 and could thus possibly be attributed to C03-for-
P04 substitution, as indicated by the XRD findings, p.84. 
Sr2 + has been found to substitute for Ca2 + in synthetic apatites causing an 
expansion in both c- and a-axis dimensions (LeGe80,LeGe84,Sil86). In the 
present study, samples 9 and 10, which are of synthetic nature, were found to 
have the highest Sr2 + levels of all the implants, but have very small a-axis 
dimensions. This demonstrates that there may be several substitutions occurring 
each with overriding effects and that no one effect can be clearly identified. 
From the above argument, it may be stated that the values of %mass contents for 
the remaining minor elements obtained in this study merely serve the purpose of 
identifying their presence within the apatites, and conclusions as to their effects 
on cell parameters cannot be argued. 
Comparison of the published reference values for the animal bone standard IAEA-
HS (Mah83) with those obtained for the standard in this study (Table 2, 
APPENDIX 2), shows that there is good agreement, thereby lending confidence to 
all of the above findings. 
Finally, Mg/Ca ratios were calculated for the implants and are listed in Table 3.6, . 
p.56. Values for all samples are very low again as a result of the high Ca levels (all 
implants) and in some cases very low Mg levels (implants 2,3,7 and 8). 
Comparison of these values with the Mg/Ca ratio obtained for the IAEA-HS 
standard of Mahanti and Barnes (0.013 as calculated from Table 2, APPENDIX 2), 
shows that only samples 1 and 4 approximate this value while the remainder are 
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much lower. This further serves to illustrate an apparent fundamental chemical 
difference between the implants and the reference bone. 
4.2.2 Bone samples 
In order to determine whether there is any variation in the chemical composition of 
bones originating in different regions of the body, as well as within any one 
individual bone itself, statistical analyses were performed. A variance component 
model was used in which the regions, sites and analyses were considered as 
random choices from a population, and are thus considered as random effects 
with a certain distribution. 
The model may thus be regarded as a three factor experiment with the region 
factor used at 6 levels, a site factor used at 2 levels, an analysis factor at 2 levels 
and 3 repeated measurements (made on the 6*2*2 combination of region, site 
and analysis). 
The observations may be represented by: 
Yijkl where i = 1 to 6 
j = 1, 2 
k = 1, 2 
and I= 1, 2 ,3 
Thus, "i" denotes the level of the region, "j" the level of the site, 
"k" the level of the analysis, and "I" used for the repeated 
measurements. 
The final model is as follows: 
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'Yij-(a,62 region x site) vik-(a,62 region x anal) €jk-(a,62 site x anal) 
"ijk-(a,62 region x site x anal) Eijkl-(a,620) 
The parameters represent the variances due to the main effects of region, site and 
analysis, the two-way interaction between the main effects and the three-way 
. interaction between the main effects. Thus a figure was obtained for the variation 
component, which simply is the percentage variation between the effects 
specified respectively. In other words, if the "varcomponent" value for a specific 
set of main effects is low, it signifies low variance in values between the two 
effects. The results for the various effects are given in Table 4.4: 
TABLE 4.4 : Varcomponent percentages 
Effect Ca P Mg 
Region 12.5 14.a a.a 
Site 27.6 34.2 a.a 
Region*site 43.2 46.1 37.a 
Analysis -a.a 4.a a.a 
Region*analysis 1.4 a.a a.a 
Site*analysis 8.6 1.a a.a 
Region*site*analysis 4.5 a.5 62.a 
Reading 2.2 a.2 1.a 
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Only the major elements were used in the model since far greater variations were 
expected to occur in the values of the minor elements as a result of these being 
present in quantities close to the detection limits of the instrument. Moreover, for 
simplicity sake, it seemed wiser to study only the main elements, since much of 
the discussions in texts have centered around these. 
It can be seen from Table 4.4 above, that the varcomponent°J'b value of the 
reading effect is very small in all three ele~ents. However, the same is not true for 
the region, site, and region*site effects, which in calcium and phosphorus 
contribute 83.3% and 94.3% respectively towards variation in the measurements 
in those elements. This implies that calcium and phosphorus levels vary to a large 
extent from one site to the next within the same bone, but that this variation is not 
significant since the error (Table 5, APPENDIX 2) is larger than the variance 
component itself. Ideally, one would need a larger sample size to decrease the 
error component to a value below that of the variance component and determine 
whether site-to-site variation is then still insignificant. However, in the present 
study it is assumed that technique error causes the site-to-site variation to be 
insignificant. 
In magnesium, the three-way interaction percentage (Region*site*analysis, Table 
4.4) is very high and the one outlier in the results of Mg levels (Table 4, APPENDIX 
2) could well be the cause. 
The second part of the statistical evaluation involved combining the two sites of 
each bone into one average reading. The aim of this was to determine the degree 
of variation within bones from different regions of the (same) body without the 
variation of the sites interfering and distorting the results. The model used in this 
case was as follows: 
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µ is the overall mean effect 
ai the effect of the i-th sample, Pj the effect of the j-th analysis, and 'Yij the effect of 
the i-level and j-level of the sample and analysis. Eijk represents the error of the 
readings. 
Table-4.5 lists the findings. 






Ca P Mg 
83. 1 94.5 72.0 
0 4.1 5.6 
14.7 1.2 20.0 
2.2 0.2 2.4 
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For all three elements there is a significant variation component, calculated at 95% 
confidence level (Est.± 1.96 Std.Error). In Ca the analysis component is estimated 
as zero and in P and Mg it is not significantly higher. However, the interaction of 
the analysis and sample components shows that there is a significant variation, 
comprising 14.7% of the total variation in Ca, only 1.2% in P, and 20% in Mg. It is 
thus concluded that only phosphorus seems to yield very consistent estimates of 
the element concentration over a number of samples. The variations of 20% in Mg 
and 14. 7% in Ca are substantial components that will cause inconsistencies in the 
element concentration determinations. The error throughout the three readings 
taken for each element is small, with P again the most consistent. 
These analyses indicate that the error component found within bones from 
different regions of the body is high but only partly (12%) attributable to . 
experimental error. Also, the error component from one analysis of a specific site 
on a bone to the next (Table 4.4) is high and greatly attributable to experimental 
error. This would imply that concentrations of the elements tested across the 
surface of a bone do not differ significantly, but that concentrations in bones from 
different regions do. This is the reason for having combined values of the two 
sites per bone sampled and merely compared the bones of the different regions 
to one another (Table 4.5), and having found them to differ significantly. 
While these results are of great interest, it must be mentioned. that other factors 
such as nutrition and degre of exercise, for example, play a significant role in the 
nature of bone. To have sampled bones from several bodies was outside the 
scope of this study, but would have made the statistical evaluation far more 
meaningful. The fact that there are indeed significant differences in the chemical 
constitution of bones from different parts of the body of the one cadaver studied, 
would certainly warrant future investigation into this area. 
101 
The final values for each bone (taken from an average of the values of the two 
sites) are listed in Table 3.12, on p.60. Based on the above findings, it is therefore 
not surprising that the Ca levels in the various bones are different to that given by 
Mahanti and Barnes (Mah83) of 27.10% (.±0.30%) (Table 3, APPENDIX 2). 
However, the Ca value for the reference standard IAEA-HS animal bone was 
found to be 19.72% (.±0.34%), which compares favourably with the published 
value (Mah83) of 21.17% (.±2.40%). 
The difference between the Ca value in this study and that obtained by the 
authors mentioned, might be attributed to the factors already mentioned which 
influence the chemical constitution of bones from one individual to the next. The 
fact that the Ca value of the standard determined in this study agrees well with the 
published value lends confidence to the results. 
4.2.3 Final comparison 
Consideration of Ca/P ratios of implants and bones, it is seen that the latter 
exhibit much higher values, even though the implants have higher Ca levels. As 
already mentioned, the reason for this could be that there is C03
2- substituting for 
Pol- in the bones, depressing the phosphorus levels and causing higher Ca/P 
ratios. It has already been established from powder diffractometry and infra-red 
studies that the bones do have higher carbonate contents than the implants, and 
this latest finding serves to substantiate those results. 
The Mg/Ca ratios of the bones also appear to be higher than those of the 
implants, perhaps signifying greater substitution of Mg2 + for Ca2 + in the former. 
However, if this were true, decreasing levels of Ca2+ in the bones should be 
observed. Since this is not the case, it is suggested that the amount of col-
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substituting for P04
3- is so great in the bones that it offsets any decreases of 
calcium in the structures. This would further confirm the other results obtained in 
the present study where the bone samples were found to have greater amounts 
of included carbonate. Moreover, it would also explain the lower Ca2 + levels in 
the bones when compared to the implants. 
Another factor which emerges from the comparison of the %mass content values 
for the implants and the bones, is that the levels of strontium are higher in the 
former. This is especially true for implants 9 and 10, which exhibit the highest 
levels of all. However, this seems to be a feature of synthetic implant materials 
(LeGe84), which these two samples indeed are. 
Thus, it can be said that the bones seem to differ significantly in chemical make-
up from region to region in the body (for the one subject studied) and that they 
also differ from the implants with respect to characteristics such as Ca/P and 
Mg/Ca ratios. 
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4.3 INFRA-RED SPECTROSCOPY 
4.3. 1 Spectra assignments 
Infrared absorbtion spectra of hydroxyapatites are characterized by vibration 
bands produced by OH, P04, and co3 groups (HasX,LeGe69, LeGe81). The 
vibrational band due to the OH group was found to occur around 3400cm-1 (with 
a smaller peak at -1640cm-1 ) for the implants as well as for the bone samples 
and was a very prominent feature on all the spectra. This compared favourably 
with reported results of hydroxyapatite infrared studies (Bad66,LeGe68,LeGe81). 
The C03 vibrational modes are given the symbols v1,v2,v3, and v4, according to 
LeGeros (LeGe81). 
Two features were immediately obvious in implant- and bone-spectra: 
i) the band at 1495cm-1 v4, which is attributed to surface and amorphous 
carbonate (HasX), was not d~tectable; and 
ii) the asymmetric stretching mode in the region 1450 to 1500cm-1 was split 
into two bands for implants and bones. 
According to LeGeros and Trautz, the greater the carbonate content of a sample, 
the stronger and more resolved will be the doublet at 1450cm-1 
(LeGe68,LeGe81). The fact that this doublet is present in both the implants and 
the bones would imply that both contain C03. However, in the bone spectra, the 
bands are wider and generally more prominent than in the implant spectra, 
possibly implying a higher content of carbonate for the bone samples. 
Comparison of this band's shape as obtained in bone and implant spectra with 
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those published in the literature (Fig 4.3), (LeGe68), shows that the bone spectra 
of the present study resemble those of biological apatite (spectrum c in Fig.4.3 ) 
more than do those of the implants, while the latter resemble the spectrum 
obtained for synthetic apatite. Since the latter contain C03-for-OH substitutions, it 
seems reasonable to suggest that the same substitutions may be present in some 
of the samples of the present study. This would explain the increase in a-cell size 
in implants 1 to 6 Table 3.1, p.52. @ 
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Another interesting aspect of all the spectra is the band, v2, for C03 in the region 
860 to 880cm·1. According to LeGeros(LeGe81), the appearance of such a band 
is usually in the form of an anomalous doublet for apatites and indicates the 
presence of co32• in two different environme11ts. These environments, as already 
outlined in the introduction, p.34, are defined as carbonate partially adsorbed and 
partially in the lattice as a substituent for either OH- and/or P04
3-. Under the 
experimental conditions, the doublet was not actually resolved, the maximum 
~. absorbtions only being visible at -875cm·1. 
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However, it should be stated that if the organic phase of bone is 
present, as in this case, the absorption bands due to N-H group 
overlaps with the C03 absorption. Thus a certain element of error 
might be present in the results of the bone samples. 
The amount of carbonate incorporated in the structures is said to be directly in 
relation to the loss of resolution of the P04
3- absorbtion bands; v4, in the region 
560 to 600cm~1 (HasX,LeGe68,LeGe81). However, inclusion of carbonate also 
has an effect on the crystallite size of the sample (LeGe81) and this will influence 
the spectra in a similar manner. Nevertheless, it can be seen from the spectra that 
the bones have less well-resolved P04
3- bands than do the implants. In some 
implants a band occuring as a shoulder (at -630cm-1 on the P043- bands can be 
identified. 
According to LeGeros and Trautz (LeGe68), this band is assigned to the OH 
group and only occurs in more crystallized samples. This band seems to be 
absent in most bone samples of the present study, with only one or two 
displaying a broadening of the base of the P04
3- band. This would be a factor 
confirming that implants have less carbonate within their structures than do the 
bones, since less carbonate causes higher crystallinity, resulting in the 
appearance of this OH band. 
It appears, from the spectra for both implants and bones, that the band in the 
region 900 to 1200cm-1 due to P04
3- group mirrors any spectral shape changes 
imposed on the Pol- bands at around 600cm-1 when crystallinities are altered. 
Therefore both these bands appear to be useful in determining qualitative 
contents of carbonate in the samples. 
For the implants, samples 1 and 9 have the sharpest P04
3- bands, (i.e. those at 
around 600cm-1 as well as around 1100cm·1). Similarly for the bones, .it is sample 
6 which has the sharpest P04 bands, perhaps signifying lowest carbonate 
contents for all of these. 
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Therefore, as a result of the difference in resolution of the P04
3- bands and the 
fact that carbonate bands are present in all the spectra, it would seem that there 
are varying amounts of co32- within the implants and bones. The fact that the 
P04
3- bands at around 600cm-1 and around 1100cm-1 are less well-resolved for 
the bones than for the implants, suggests possible higher levels of carbonate in 
the former. Furthermore, the appearance of the OH band at around 630cm-1 for 
the implants would further substantiate the hypothesis that the implants contain 
less carbonate than the bone counterparts. @ 
4.3.2 %C03 Levels 
From Tables 3.17 and 3.18 on p.64 and 65, it is immediately obvious that the 
carbonate levels of the bones appear to be higher than those of the implants. 
Consideration of the implants individually, reveals that %C03 values appear to be 
similar except for numbers 8 and 9, where lower values are manifested by sharper 
P04
3- bands. Similarly bone sample 6 appears to display lowest %C03 levels, 
again confirmed by the sharpest P04
3- bands. Thus it would appear that the 
theory concerning the resolution of the P04
3- bands (HasX,LeGe68,Sil86) in the 
spectra of both types of samples agrees well with the findings of carbonate levels, 
thus lending confidence to the technique of carbonate-determination by the use of 
standards as outlined by Featherstone and LeGeros (Fea84). 
4.3.3 C03/P04 Ratios 
These are given for the implants and the bones in Tables 3.19 and 3.20 
respectively on p.66. 
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Other bands in the bone samples shown in Appendix 3 were bot assigned 
but some of these are 4ue to the organic component. 
Consideration of C03/P04 ratios shows that large errors are involved which lends 
a degree of uncertainty to the results. These errors might have emerged as a 
result of possible inaccurate estimation of the base of the relevant absorbtion 
band. 
The C03/P04 ratios for the bones and implants did not differ as much as might 
have been expected on the basis of their different C03 contents. However, the 
values obtained for both sample-types appear to be in the correct "range" when 
compared with published values (Are75), Table 4.4. Therefore, the results of this 
part of the study . should not be viewed as absolute but rather as indicative of 
trends concerning carbonate contents. The C03/P04 ratio study thus confirms a 
trend towards lower ·carbonate contents in the implants relative to the bones, 
thereby lending the bones a less crystalline nature. 
TABLE 4.4: Values of C03/P04 from reference experiments(Are75) 
%C03 by mass S.D. 
0.300 0.006 4.43 0.05 
The values given in Table 4.4 were obtained for sound bovine enamel pooled from 
four teeth. 
The Infra-red technique was found to be successful as it met the objectives of this 
part of the study: 
108 
i) bands were assigned to their respective groups; 
ii) the %C03 contents were calculated for the implants as well as the bones; 
iii) C03/P04 ratios were calculated and trends correlated with %C03 results; 
and 
iv) the findings were found to correlate well with results of XRD. 
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4.4 THERMAL DECOMPOSITION 
In discussing the results of this experiment, reference will be made to the tables of 
diffraction maxima obtained after heating (APPENDIX 4). 
4.4. 1 Water loss 
When heating a sample such as apatite, the first component to be eliminated from 
the structure is water (LeGe78,Bar84). Recent studies have demonstrated that 
there are two types of water present (LeGe78,Hol80, LeGe81,Bar84): 
i) "adsorbed H20"; 
ii) "lattice H20". 
The adsorbed water is reversible, that is, once lost due to heat, it can readsorb 
upon cooling (e.g. from atmosphere). The loss of this water has no effect upon 
the cell parameters (LeGe81). However, lattice water, which is due to H20-for-OH 
and/or HP04-for-P04 substitution, when lost, does influence the cell parameters 
by causing a contraction in a-axis dimension (LeGe78,Hol80). 
Inspection of the masses lost upon heating (Table 3.21, p.67), shows that for the 
implants, the %losses up to 200°C were of the order of 1.50%. This would suggest 
the presence of adsorbed water. Figs.4.4 and 4.5 demonstrate typical curves of 
mass loss vs temperature for implants and bones respectively. There was only 
slight variation in the amount of water lost from implant to implant, with the notable 
exceptions of implants 7 and 10, which exhibited the lowest losses. It would seem 
thus, that the implants are relatively similar with respect to their capacity to hold 
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water on the crystal surface, with samples 7 and 1 O having the lowest such 
capacity. 
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In the bones, however (Fig.4.5), the %losses at 200°c were of the order of 10%, 
suggesting a much higher adsorbed water content for these samples. Again, only 
small variations of the amount of water lost occurred from sample to sample, 
except for sample 4, which exhibited a 6.14% loss. It can be concluded from these 
findings that the presence of adsorbed water in both the implants as well as the 
bones is confirmed, but that the amount held by the implants is far less. 
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The following stage in the experiment involved heating to 650°C. Any losses 
observed in this range are due to decomposition of the organic phase (if present) 
and elimination of lattice water (Aok77,Hol80, Bar81).The Tables of mass-losses 
show that the implants exhibit losses in the range of 0.6 to 1.50%, with the 
exception of sample 1, which lost 3.95%. These figures are rather low when 
compared to those of bone, which are in the 30 to 40% range. This would suggest 
an expected organic phase (collagen) present in the bones, whereas none can be 
found for the implants. The slight losses exhibited by the implants could possibly 
be attributed to some lattice water having been present. Lattice water is probably 
also present in the bones but the organic losses would have overridden these 
effects. 
Since we have these losses occuring, changes in the lattice parameters as well as 
altered crystallinity values are envisaged (LeGe78). 
4.4.2 Cell parameters and crystallinity 
Table 3.22, p.68 lists the lattice parameters and crystallinities of the implants as 
found after heating to 650°C. A slight shrinkage of the a-cell sizes can be 
observed when compared to original values listed in Table 3.1, p.52, while the c-
cell sizes have not altered. The shrinkage in the a-lattice parameter can possibly 
be ascribed to the loss of lattice water (LeGe78,LeGe81)~ Another feature which 
can be observed from Table 3.22, is that the crystallinity of the samples increased 
(i.e. d002 peak widths decreased). Perhaps this might be attributed to possible 
losses of traces of carbonate (as C02 gas). According to reports, a loss of 
carbonate from the structure results in an expansion of the a-cell parameter 
(LeGe78,LeGe81), and would increase the crystallinity of the sample. The 
observation of increased crystallinity correlates well with this, but perhaps the loss 
112 
of lattice water influences the effect of carbonate loss on the a-cell size to such an 
extent, that it masks it. Hence the slight contraction can be explained in this 
manner. For the bones, a somewhat different scenario arises. It has already been 
suggested that the high mass-losses observed here are due to the decomposition 
of the organic phase and that · lattice water is probably being lost as well. 
However, no significant changes in cell parameters can be observed (Table3.24, 
p.69). Even the crystallinity values have not altered. This would suggest that the 
loss of 30-40% mass observed in the bones is mainly due to the loss of organic 
material, which might possibly be accompanied by minimal (and thus undetected) 
loss of lattice water. Little or no carbonate has been lost at this stage. This would 
imply an inherent difference between the bones and the implants in that some 
carbonate seems to have been lost when heating the implants to 650°C, as 
manifested by the increased crystallinity. 
The final stage of the experiment involved heating to 900°C. The implants exhibit 
mass losses in the range of 0.6 to 1.5% after completion of heating (Fig.4.4). The 
losses may be attributed to the elimination of carbonate from the crystal 
structures (LeGe78,Hol80,LeGe81 ). However, the increase in a-cell parameter 
which would accompany such a loss is not detected here, a possible reason 
being that it is so small that the error margin masks it. This would suggest very 
small amounts of carbonate lost during this stage. Crystallinity values show that 
although the widths of the 002 peaks have decreased, implying increased 
crystallinity, these have not occurred to a great extent. This would confirm the fact 
that although some carbonate may have been lost during the heating from 650 to 
900°C most of it had been eliminated in the previous stage. 
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The bone samples also exhibited only small changes in a-cell parameters, but a 
rather noticeable increase in crystallinity. Perhaps this would suggest loss of 
carbonate, but that it did ·not manifest itself appreciably in the cell-dimension. ~ 
A study undertaken by Holcomb and Young (Hol80) on tooth enamel, reported a 
contraction of a-cell size of 0.012A after heating to 400°C, and a subsequent 
expansion of the a-unit size of 0.013A after heating to 800°C. In the present study, 
the former was observed in the implants. For the bones, however, any changes 
that might have occurred were within the error margin and consequently, could 
not be detected. 
Hence, the fact that crystallinities for both the implants and the bones have 
increased after heating to 900°C, suggests carbonate losses from their structures. 
However, the temperatures at which these losses occur differ from implants to 
bone, with most of the carbonate being released from the implants at 
temperatures below 650°C (confirmed by crystallinities), and at temperatures 
above 650°C for the bones. Both types of sample exhibited loss of surface water 
below 200°c. A major portion of the final mass lost in the bones was due to the 
decomposition of the organic phase, which was found (as expected) to be 
inherently absent in the implants. 
4.4.3 Crystal phase 
Attempts were made to identify the crystal phases prevalent after each heating 
stage. According to LeGeros, when carbonate substitutes into the apatite 
structure, it does so in the place of HPol- (LeGe81). The appearance of 
tricalcium phosphate in biological apatites which have been heated to 700°C has 
been attributed to the original HPol- content of the material. Therefore, the 
greater the extent of substitution of C03-for-HP04 in the structure, the less will be 
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Another possible explanation would be that 
the organic phase) gives poorly resolved 
that accurate measurements of the a-axis 
difficult, a factor compounded by the fast 
whole bone (i.e. containing 
X-ray diffraction peaks and 
from the 300 peak are made 
scan speed used. 
the extent to which /J-TCP is present. Since in the present study infra-red 
spectroscopy and X-ray powder diffractometry have shown that such a 
substitution occurrs to a much greater extent in the bones than the implants, it 
would be expected that the spectra of the bones (after heating to 900°C) would 
bear less evidence of /J-TCP than the implants. 
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Inspection of the · spectra recorded for the implants after they were 
heated.. to 650 ° C <APPENDIX· 4), --shows - that·-· the crystal 'phase is 
hydroxyapati te, e,xcept for_ samp1les 9 anq 10, which display traces of 
whitlockite in addition to hydroxyapatiteJ·· '', .l'!':~I.. L '..I 
tre:ees ef ~ TCP a1 e appar er rt However, the spectra recorded after heating the 
implant samples to 900°C, revealed different results. The XRD spectra of some of 
the implants (2 and 3) revealed the following incriminatory features: 
i) a maximum intensity peak at d = 2.87 A; this is closer to the maximum 
intensity peak of /J-TCP (d=2.84A) than of HA (d=2.81A); 
ii) an enhanced peak at d = 3.17 A of relative intensity 63%; for pure HA this 
peak is expected to have a relative intensity of 10% while for /J-TCP it is 
expected to have a relative intensity of 40%; 
iii) a peak at d = 2.61 A with a relative intensity of 70%; peaks occur in the HA 
spectrum at d = 2.53A and d = 2.63A with respective relative intensities of 5% 
and 31% while /J-TCP has a peak at d=2.58A with a relative intensity of 
55%. 
Therefore, implants 2 and 3 probably contain traces of /J-TCP. 
Finally, the presence of Cao was investigated. A peak at d=2.40A with a relative 
intensity of 13% is characteristic (LeGe81) of this substance. Accordingly, 
implants 2,3,9 and 10 were found to contain traces of Cao. 
The bone spectra were inspected in a similar manner. In all bone samples, HA 
was found to be the only crystal phase prevalent after heating to 650°C. However, 
the spectra obtained after heating to 900°C revealed traces of Cao in all the 
samples except number 2. No traces of P-TCP were found. 
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Thus, the results of this part of the study have confirmed that the presence of 
C03
2- as a substituent for HPol-. reduces the extent to which P-TCP phase -
forms after heating above 700°C. This correlates well with the initial findings of this 
study (XRD and IA) that the implants have lower C03
2- contents than the bones. 
In experiment 14, the specific range in which this critical point is suspected, was 
explored. This showed that a turning point occurs in the range 0.3 to 0.4M NaGI 
solution (Fig.4. 7). 
Fig.4.7 - %Ca vs NaCl molarity 
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When CaCl2 was used as the ionic medium (Experiment 15), the initial 
concentrations of the exogenous Ca2 + (aq) solutions ranged from 0.01 M to 
1. ?OM. From Table 3.28, p. 73, it can be seen that the percentage calcium content 
detected in all the samples after exposure to the latter solutions are about 24%. 
Since this exceeds the normal expected value of 20.84%(.±.0.25%) in untreated 
bone (as determined in this study) it is suggested that exogenous Ca2 + has been 
included in the lattice, but that the threshold level was attained even with the 
solution of concentration 0.01 M. Hence, experiment 16 was set up to explore a 
lower concentration range. Table 3.29, p.74 lists the concentration range used 
and the %Ca levels attained in the samples after exposure. The first two samples 
exhibited a "normal" level of Ca. Thereafter, a definite increase in the Ca content is 
observable, up to maximum of about 24% for the final two solutions. This trend is 
illustrated in Fig. 4.8. 
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Fig 4.8- %Ca vs CaCl2 molarity 







A turning-point at about 0.001 M exogenous concentration is clearly visible. 
Saturation is achieved where the exogenous Ca2 + concentration is about twice 
that at the turning point. Therefore, the surface-reaction with CaCl2 occurs within 
a narrow band of exogenous calcium con-centrations, and exhibits a 
characteristic turning-point as well as a saturation level. 
4.5.2 Implant materials 
Having established the turning-points and saturation levels produced by the 
different ionic solutions for the bone samples, implants 1,2,3,4,5,6, and 10 were 
studied individually. The results (pgs. 7 4-82) show that no changes occurred in Ca 
or Na content of the implants after exposure to the ionic solution~hus, although 
surface exch?nge or adsorption processes may occur at higher exogenous 
concentrations than those tested, the results nevertheless have illustrated a 
fundamental difference in the chemical nature of bone and the implants. 
119 
This observed -difference between bone samples and implants could be 
due to differences .in crystallinity (crystal size) and therefore 
surface area. The organic phase in the bone samples may also be a 
factor. -. 
5. CONCLUSION 
Biocompatibility is a crucial factor in determining whether a given implant is likely 
to function correctly. The present study has shown that inherent physico-
chemical differences prevail between implant materials and human bone. 
Moreover, these differences are not limited to an implant vs bone comparison 
since the properties of implants themselves vary depending upon whether they 
are of natural or synthetic origin and variations also exist between different types 
of bone. The problem of matching an implant substance with the bone in which 
it is to be embedded is thus a formidable one. It is recognised that it would be 
impractical to perform physico-chemical experiments such as those described in 
this project whenever implantation is required. However, this thesis has 
demonstrated that many such properties can be successfully determined. The 
techniques and experiments which have been described enabled the objectives 
of the project to be fulfilled. Hence they can be utilised by other investigators 
who might wish to address some of the important questions which were 
raised but which were beyond the scope of this study. For example, an intriguing 
result of the present study is the finding that physico-chemical properties seem 
to vary between bones originating in different regions of the human body. Since 
only one skeleton was studied in this work, this aspect of bone composition 
needs to be explored further. An obvious follow-up question is whether similar 
variations occur between the same bone types but from different individuals. 
Such questions are of importance as biocompatibilty is dependent on these 
factors. 
The present thesis has provided a firm foundation upon which further studies 
can be based. It is suggested that the techniques and experiments which have 
been described might be used to answer the above-mentioned questions 
concerning bone composition and that, in addition, a large series of different 
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. implant materials of both natural and synthetic origin might be subjected to 
physicochemical characterization. In this way, researchers might be able to draw 
firm conclusions and perhaps provide a set of definitive guidelines for the 
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Typical XRD scan for the implants 
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Listing of d-spacings vs intensities for.the bones 
1 2 3 4 5 6 
d I d I d I d I d I d I 
4.09 21.62 4.07 15.68 4.07 16.73 4.05 22.62 . 4.03 19.73 4.07 15.81 
3.90 18. 15 3.90 16.77 3.89 17.74 3.88 23.94 3.88 19.86 3.84 16.67 
- - - 3.72 18 .31. 3.75 16. 13 3.74 12.87 
3.45 10.01 3.46 40.72 3.46 38.99 3.43 42.25 3.43 19.99 3.42 34.56 
3 .18 18.27 3 .17 17.36 3 .17 18.24 3 .15 19. 72 3. 16 18.67 3 .16 15.81 
3.09 24.36 3.09 23.23 3.08 27.64 3.07 26.62 3.07 25.33 3.07 20.71 
2.82 100 2.82 100 2.81 100 2.81 100 2.82 100 2.81 100 
2.80 90 .13 - - 2. 78 91.27 2.76 87.33 -
2.73 60.58 2.73 58.08 2.73 59.62 2. 72 61.97 2.71 63.20 2.72 56.74 
2.64 26.46 2.64 25.75 2.64 27.55 2.62 27.46 2.61 26.00 2.62 24.38 
2.54 9.89 2.54 9.82 2.54 10 .18 2.54 10.98 2.51 11 .87 2.53 9.68 
2.36 11.17 2.35 9.58 2.35 13 .33 2.34 11.27 2.34 9.20 2.34 8.33 
2.28 20.85 2.26 22.16 2.26 21.07 2.26 21.08 2.26 23.33 2.26 20.58 
2.16 8. 72 2 .15 8.50 2.15 8.80 2 .15 10.98 2 .14 9.20 2.14 7.84 
2.07 8.03 2.07 7.78 2.07 8 .17 2.06 9 .15 2.06 8.00 2.06 7 .10 
2.03 12.61 2.03 13.29 2.03 21.38 2.03 12.53 2.03 14.80 2.03 13~48 
2.00 7.55 2.00 7.40 2.01 7.81 - - -
1.95 23.21 1.95 23.95 1.95 22.54 1.94 25.49 1.94 26.00 1.94 22 .18 
1.89 16.44 1.89 15.09 1.89 14.91 1.89 15.56 1.88 16.67 1.89 14.34 
1.84 22.32 1.84 25.39 1.85 24.96 1.83 25.53 1.83 17.33 1.83 22 .14 
1.81 17.58 1.81 16.76 1.81 16.35 1.80 16.90 .. 1.80 17.60 1.80 15.29 
1. 78 15. 11 1. 78 14.55 1. 78 15.09 1. 78 16. 19 1. 77 13.60 1.77 12.97 
1. 76 12.68 1. 76 12.69 1.76 14.46 1. 76 13 .23 1.75 12.67 1.76 11.62 
1. 72 11.54 . 1. 72 14.37 1. 72 12.58 1. 72 12.76 1. 72 12.80 1. 72 11.44 
APPENDIX2 
Table1 : Masses used for the ICP determinations 
Implant Mass (g) Bone Mass (g) 
1 0.0989 1 0.0985 
2 0.0992 2 0.0990 
3 0.0991 3 0.0991 
4 0.0999 4 0.0995 
5 0.0991 5 0.0988 





Mass of IAEA-H5 standard analysed was 0.096g. 
Table 2 : Published (Mah83) and found (this studj'.) values for IAEA-H5 standard 
Published values Own values 
Element %Content S.D. %Content S.D. 
Ca 21.17 .2.40 19.72 0.34 
p 9.578 0.69 9.01 0.35 
Mg 0.353 0.0025 0.311 0.012 
Na 0.477 0.097 0.455 0.033 
Sr 104.85 17.61 µg/g. 0.0098 1.21 *10-4 
Fe 80.65 11.00 II 0.085 1.85*10-4 
Zn 89.91 15.39 6.11 *10-5 2.26*10-5 
Table 3 : Reference values for human bone (Mah83) 
Element %Content S.D. 
Ca 27.10 0.30 
p 13.80 0.20 
Mg. 0.226 0.004 
Na 1.066 0.02 
Sr 149.0 2.0 lg/g 
Fe 29.40 0.60" 
Zn 102.0 . 1.00 II 
See next page for Table 4 (raw data for statistical evaluation). 
Table 5: Log-estimates and resgective standard errors for the bones 
Ca p Mg 
. Est. S.D. Est.. S.D . Est. S.D. 
Region 3767.9 8079.2 960.2 1912.9 0 0 
Site 8342.3 12286.6 2419.6 3070.6 0 0 
Region*Site 13024.8 9116.0 3239.5 2135.5 4355.3 3562.4 
Analysis 0 0 273.3 416.8 0 0 
Region* Analysis 416.2 906.3 0 0 0 0 
Site*analysis 2604.7 2889.9 75.6 118.7 0 0 
Region*Site* Analysis 1373.2 1019.1 39.1 19.8 7159.5 2935.7 







































































0. 1 20 
------------------------------------------------------ REGION=1 SITE=l ANAL=2 ------------------------------------------------------
CA 3 2202.66666667 
p 3 995.33333333 
MG 3 429.00000000 
LOGC 3 7.69742222 
LOGP 3 6.90307354 











































------------------------------------------------------ REGION=1 SITE=2 ANAL=l ------------------------------------------------------
CA 3 2503.33333333 13.31665624 
p 3 1135 :00000000 3.46410162 
MG 3 241.00000000 0.00000000 
LOGC 3 7.82536904 0.00531464 
LOGP 3 7.03438482 0.00305477 
LOG MG 3 5.48479693 0.00000000 
2492.0000000 



































------------------------------------------------------ REGION=1 SITE=2 ANAL=2 ------------------------------------------------------
CA 3 2348.33333333 27.57414248 
p 3 1109.00000000 3.46410162 
MG 3 246.00000000 0.00000000 
LOGC 3 7.76141522 0.01173392 
LOGP 3 7.01121073 0.00312645 





































------------------------------------------------------ REGION=2 SITE=l ANAL=l ------------------------------------------------------
CA 3 2237.33333333 28.57154762 
p 3 1013.00000000 4.00000000 
MG 3 272.66666667 4.04145188 
LOGC 3 7.71298565 0.01276121 
LOGP 3 6.92066631 0.00394869 





































------------~----------------------------------------- REGION=2 SITE=l ANAL=2 ------------------------------------------------------
CA 3 2323.00000000 7.00000000 
p 3 1001. 33333333 4.04145188 
MG 3 340.33333333 20.20725942 
LOGC 3 7.75061171 0.00301336 
LOGP 3 6.90908230 0.00403139 













































































































-------~---------------------------------------------- REGION=2 SITE=2 ANAL=2 ------------------------------------------------------
Ct. 3 2348.00000000 19.07878403 
p 3 1098.33333333 6.11010093 
MG 3 265.00000000 0.00000000 
LOGC 3 7.76129715 0.00813088 
LOGP 3 7.00153885 0.00555830 


































0. 1 05 
0.079 
0.000 
------------------------------------------------------ REGION=3 SITE=l ANAL=l ------------------------------------------------------
CA 3 2219.33333333 
p 3 977.66666667 
MG 3 310.00000000 
LOGC 3 7.70489738 
LOGP 3 6.68516100 





































------------------------------------------------------ REGION=3 SITE=1 ANAL=2 ------------------------------------------------------
CA 3 2204.33333333 3.05505046 
p 3 957.00000000 3.60555128 
MG 3 310.00000000 0.00000000 
LOGC 3 7.69817976 0.00138623 
LOGP 3 6.86379866 0.00376485 





































------------------------------------------------------ REGION=3 SITE=2 ANAL=l ------------------------------------------------------
CA 3 2250.33333333 
p 3 971.00000000 
MG 3 254.00000000 
LOGC 3 7.71882703 
LOGP 3 6.87832541 
LOGMG 3 5.53733427 
10.01665280 2240.0000000 



































------------------------------------------------------ REGION=3 SITE=2 ANAL=2 ------------------------------------------------------
CA 3 2151. 33333333 
p 3 942.00000000 
MG 3 263.33333333 
LOGC 3 7.67381243 
LOGP 3 6.84800189 
LOG MG 3 5.57219187 
20.59935274 2128.0000000 
3.00000000 939.0000000 































0. 1 25 
0.047 
1. 084 













---------------------------------------.--------------- REGION=4 SITE=l ANAL=l ------------------------------------------------------
CA 3 1850.66666667 
p 3 843.66666667 
MG 3 198.00000000 
LOGC 3 7.52327477 
LOGP 3 6.73775497 
LOG MG 3 5.28826703 
16.50252506 1837.0000000 
































0. 1 18 
0.041 
0.000 
------------------------------------------------------ REGION=4 SITE=1 ANAL=2 -------------------------------------------------
CA 3 1916.00000000 
p 3 826.00000000 
MG 3 216.00000000 
LOGC 3 7.55799141 
LOGP 3 6.71659477 





































------------------------------------------------------ REGION=4 SITE=2 ANAL=1 --------------------------------------------------
CA 3 2342.66666667 
p 3 1 081. 33333333 
MG 3 684.00000000 
LOGC 3 7.75903997 
LOGP 3 6.98594548 





































------------------------------------------------------ REGION=4 SITE=2 ANAL=2 ------------------------------------------------------
CA 3 2271 .66666667 27.73685875 
p 3 1025.66666667 7.50555350 
MG 3 303.00000000 0.00000000 
LOGC 3 7.72821921 0.01223807 
LOGP 3 6.93308023 0.00731966 



































0. 1 06 
0.000 
------------------------------------------------------ REGION=5 SITE=l ANAL=l ------------------------------------------------------
CA 3 1872.00000000 
p 3 896.33333333 
MG 3 152.00000000 
LOGC 3 7.53468976 
LOGP 3 6.79830849 
LOGMG 3 5.02388052 




































------------------------------------------------------ REGION=5 SITE=1 ANAL=2 ------------------------------------------------------
CA 3 1952.00000000 
p 3 881. 33333333 
MG 3 153.00000000 
LOGC 3 7.57660319 
LOGP 3 6.78143534 


















































------------------------------------------------------ REGION=5 SITE=2 ANAL=1 ------------------------------------------------------
CA 3 2262.33333333 6.65832812 2255.0000000· 2268.0000000 3.84418753 6787.0000000 44.3333333 0.294 p 3 1055.66666667 4.50924975 1051. 0000000 1060.0000000 2.60341656 3167.0000000 20.3333333 0.427 
MG 3 168.33333333 34.84728588 131. 0000000 200.0000000 20. 11908988 505.0000000 1214.3333333 20.701 
LOGC 3 7.72414912 0.00294466 7.7209053 7.7266537 0.00170010 23.1724474 0.0000087 0.038 
LOGP 3 6.96192167 0.00427251 6.9574974 6.9660242 0.00246673 20.8857650 0.0000183 0.061 
LOGMG 3 5.11085666 0.21563853 4.8751973 5.2983174 0.12449896 15.3325700 0.0465000 4. 219 
------------------------------------------------------ REGION=5 SITE=2 ANAL=2 ------------------------------------------------------
CA 3 2309.33333333 44.43347087 
p 3 1013.33333333 4.61880215 
MG 3 218.00000000 0.00000000 
LOGC 3 7.74459155 0.01914817 
LOGP 3 6.92099357 0.00456406 





































------------------------------------------------------ REGION=6 SITE=l ANAL=l ------------------------------------------------------
CA 3 2113. 33333333 
p 3 997.00000000 
MG 3 200.00000000 
LOGC 3 7.65578720 
LOGP 3 6.90475077 





































------------------------------------------------------ REGION=6 SITE=! ANAL=2 ------------------------------------------------------
CA 3 2201.66666667 
p 3 970.00000000 
MG 3 200.00000000 
LOGC 3 7.69695821 
LOGP 3 6.87729501 
LOGMG 3 5.29831737 
13.05118130 2188.0000000 



































------------------------------------------------------ REGION=6 SITE=2 ANAL=1 ------------------------------------------------------
CA 3 2336.00000000 10.58300524 
p 3 1043.00000000 4.00000000 
MG 3 202.00000000 0.00000000 
LOGC 3 7.75618849 0.00453542 
LOGP 3 6.94985155 0.00383511 





































------------------------------------------------------ REGION=6 SITE=2 ANAL=2 ------------------------------------------------------
CA 3 2217.33333333 57.72636602 
p 3 1018.00000000 4.00000000 
MG 3 202.00000000 0.00000000 
LOGC 3 7.70383323 0.02615418 
LOGP 3 6.92559005 0.00392930 
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Typical IR scan of the bones . 
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Typical XRD scans of the implants after each heating stage 
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Listing of d-spacings vs intensities for 
to 650"C 
1 2 3 
d I d T d I d .... 
4.07 11.83 4.09 17 .. 31 4.07 10.92 4.07 
4.00 11 . 31 3.89 19.02 3.88 30.74 3.88 
3.61 10.28 3.60 19.75 3.61 6.29 3.50 
3.45 33.54 3.45 44.39 3.45 51.11 3.45 
3 .19 11.95 3 .19 18.78 3.29 11.85 
3 .10 19.92 3.10 27.56 3 .14 13. 15 3 .16 
3.03 9.76 3.02 24.63 3.06 28.05 3.08 
2.95 21.98 2.94 36.58 2.99 14.81 
2.84 100 2.82 100 2.90 15.00 2.82 
2.81 52.95 2.80 73.90 2.80 100 2.79 
2. 72 61.18 2. 72 58.78 2.72 65.00 2.73 
2.64 22.75 2:64 27.07 2.63 37.96 2.64 
2.61 32.59 
2.54 7.45 2.53 11. 71 2.52 10.00 2.54 
2.40 6.29 
2.37 6.68 2.34 10.97 2.33 12.59 2.35 
2.29 9 .12 2.30 13.41 2.29 11.01 2.30 
2.26 24.68 2.26 24.39 2.25 26.38 2.27 
2.23 4.37 2.23 10.24 2.18 9.25 2.23 
2.20 
2 .16 9.25 2 .15 14.63 2 .13 10.45 2.15 
2. 11 
2.07 7.71 2.06 12.92 2.06 7.40 2.06 
2.03 8.48 2.04 20.00 2.03 21.48 2.03 
2.00 7. 77 2.00 12.44 1.99 9.26 2.00 
1.94 31.88 1.95 33.65 1.94 40.46 1.95 
1.89 16.71 1.89 21.71 1.88 16.48 1.89 
1.87 8.74 1.87 
1.83 32.00 1.84 36.34 1.83 34 .16 1.84 
1.80 20.56 1.80 20.00 1.79 19.44 1.80 
1. 77 13. 11 1. 77 16.48 1. 78 
1. 75 13. 13 1.75 15. 12 1. 74 15.27 1.75 
1. 72 14. 13 1. 72 19.02 1 • 71 18.51 1. 72 
the implants after heating 
4 5 
I d I 
8.92 4.07 6.52 
9 .12 3.88 7.55 
5.25 -
35.51 3.46 35.53 
10. 11 3 .16 10.33 
17 .86 3.07 16.05 
3.00 7.47 
100 
52.57 2.80 100 
64.48 2.72 51.51 
23.41 2.62 10.83 
6.44 2.52 6 .36 . 
3.79 2.34 6.20 
7 .14 
24.40 2.25 20.27 
3.17 
2.57 
7.44 2 .15 7.55 
2.97 
5.95 2.06 7.47 
7.04 2.03 11.88 
5.35 1.99 6.83 
29.36 1. 93 24.00 
13.49 
5.05 1.87 14. 15 
32.24 1.83 28.22 
17.06 
12.89 1.79 15.89 
1.76 14.22 
12.99 1.74 12.32 
14.58 1. 72 14.22 
cont'd 
6 7 8 9 10 
d I d I d I d I d I 
4.09 10.81 4.07 8.58 4.09 10.59 4.07 12.21 4.09 9.26 
3.88 8 .95 3.88 8.57 3.89 10.59 3.88 12.35 3.88 9 .03 . 
3.50 5.37 3.50 5.28 3.51 6.56 3.50 3. 14 J.47 5.04 
3.45 33.95 3.44 34.97 3.45 37.71 3.44 47.48 3.45 59.48 
3.34 6.99 
3 .16 10.57 3 .17 12. 71 3 .16 14.24 3 .17 15.66 
3 .17 11.02 3.07 17.90 3.08 19.27 3.08 19.67 3.08 23.64 
3.08 18.16 2.86 12.21 
2.82 100 2.82 100 2.81 100 
2.81 100 2.80 100 
2.77 51.88 2.76 53.40 2. 77 55.08 2.78 65.81 2.78 62.75 
2. 72 64.31 2.71 62.82 2. 72 61.86 2.72 59.02 2. 72 60.23 
2.63 23 .14 2.62 23.98 2.63 23.31 2.62 25.24 2.61 32.41 
2.52. 6.28 2.53 6.78 2.52 7.84 2.51 7.83 
2.54 6.48 2.34 2.62 2.34 6.05 
2.35 3 .12 2.29 7.22 2.30 8.05 2.29 8 .14 2.28 9.33 
2.30 7.37 2.25 23.03 2.26 25.21 2.26 21.57 2.25 28.23 
2.26 25.01 2.22 3.22 2.22 4.01 
2.22 3.23 2.14 7.22 2.15 8.26 2 .15 8 .14 2.14 10.01 
2.15 2.64 2.06 5.76 2.06 6 .14 2.06 8 .14 2.05 10 .16 
2.11 7.48 
2.06 2.87 2.03 4.81 2.03 3 .17 2.03 4~07 2.02 11.29 
2.03 6.09 2.00 5.03 2.00 4.97 1.99 6.51 1.99 7.83 
2.00 5.21 1.94 29.53 1.94 27.54 1.94 26.59 1.93 38.40 
1.91 4 .13 1.91 4 .14 
1. 95 29.61 1.88 13.45 1.89 12.71 1.89 13. 70 1.88 18.67 
1.88 5.07 1.86 5.34 1.87 5.51 1.86 6 .10 . 1.86 8.50 
1.86 5.34 1.83 33.24 1.84 29.87 1.83 32.56 1.83 45.03 
1.84 32. 72 1.80 17.27 1.80 16.73 1.80 13.83 1.80 20.48 
1.80 17 .41 1. 77 12.56 1. 77 12.07 1. 77 11.53 1. 77 15.81 
1.77 12.56 1.75 13.29 1.75 13 .13 1.75 11.39 1. 72 16. 18 
1. 75 12.91 1. 71 14.87 1. 72 16.95 1. 72 16 .14 1.71 21.46 
1. 72 14.98 
Listing of ct-spacings vs intensities for the implants after heating 
to 900 "C -
1 2 3 4 5 
d I d I d I d I d I 
- 4.39 16.39 4.39 13.62 - -
4.05 10.67 4.07 23. 18 4.05 22.81 4.07 9.94 4.09 17.25 
3.88 10.37 3.89 17.33 3.88 5. 18 3.88 10.36 3.89 14.36 
3.49 6.02 3.49 11 .49 - 3.50 6. 17 3.51 7.41 • 
3.43 36.84 3.43 58.03 3.43 45.78 3.43 37.48 3.43 70.65 
- 3.36 14.75 3.36 18.51 - -
3. 16 10.86 3.20 63.23 3.20 90.96 3. 17 10.37 3. 17 1.9 .28 
3.07 18.56 3.07 18.97 3.09 5.40 3.08 19 .16 3.08 38.88 
- 3.00 22.25 3.01 29.62 - -
- 2.87 100 2.87 100 - -· 
2.81 100 2.81 78.68 2.81 9.55 2.81 100 2.81 100 
2. 77 51.55 2. 77 48.95 - 2.77 52.15 2.77 94.06 
- 2.76 34.89 2.75 41.33 - -
2.73 66.47 2. 72 62.53 2. 72 21.48 2.72 61.98 2. 72 97.73 
2.63 24.69 2.64 14.51 2.67 16.51 2.65 5.86 2.63 46.21 
- 2.61 70.25 2.60 99.70 2.62 24.08 -
- 2.54 16.39 2.55 22.07 - -
2.51 6.71 2.51 17.56 . 2.51 2·0.88 2.52 6.91 2.52 12.80 
- 2.40 12.88 2.40 18.67 - -
- 2.37 11 .24 2.37 12.74 - 2.34 6.40 
2.29 7.71 2.29 9.36 2.29 3.92 - 2.29 13 .66 
2.26 . 25.58 2.25 31 .38 . 2.25 22.22 2.23 7.01 2.26 52.92 
2.22 33.58 2. 19 16.39 2. 19 25~11 2. 19 23.03 -
2.14 7. 11 2 .15 14.75 2. 16 19.85 2. 16 3. 14 2 .15 15.61 
2.09 2.96 - - 2.09 7.64 2.11 4.91 
2.06 5. 72 2.06 43.90 2.07 16.00 2.05 3.87 2.06 10.53 
2.03 2.95 2.02 14.05 2.02 28.00 2.01 5.65 2.02 15.84 
1.99 5.03 1.99 11.71 2.00 12.59 - 1.99 9.36 
1.94 29.23 1.93 32.08 1.93 10.29 1.95 5.44 1.94 58.78 
1.89 13.63 1.88 23.63 1.89 27.11 1 • 91 29.63 1.89 27.11 
1.86 5.53 - 1.88 25.03 1.87 12.56 1.87 11.47 
1.83 29.63 1.83 25.76 1 .83 3.92 1.83 30.47 1 .84 61.67 
1.80 27.06 1.80 18.73 1 . 81 10.81 1.79 15.70 1.80 35.91 
1. 77 11. 95 1.77 17 .09 1. 77 17.25 1.77 11.94 1. 78 28.49 
1.75 13.33 1. 75 13.11 1. 74 7.92 1. 74 12.46 1. 75 27. 16 
1. 72 12.34 1. 72 34.89 1. 72 41.70 1. 72 14.24 1. 72 27.71 
- 1. 70 14.75 1.70 16.80 - -
cont'd 
6 7 8 9 10 -
d I d I d I d I d I 
- - - -
4.09 6.36 4.05 9. 10 4.07 13.90 ·4.09 10.41 4.05 9.38 
3.88 6 .96 3.88 9.50 3.88 12.38 3.88 9.93 3.88 9. 10 
- 3.50 6.00 3.51 6.85 3.50 5.37 3.49 4.51 
3.43 37.27 3.43 37.80 3.43 64.44 3.43 61 • 31 3.43 40.38 
- - - 3.34 4.48 -
3 .17 10.68 - - 3.20 13.86 -
3.07 15.45 3 .15 11.80 3. 17 18.92 3. 17 17. 10 3 .15 10.76 
- 3.07 17.90 3.09 31.24 3.08 23.24 3.06 22 .17 
- - - 2.99 4.69 -
2.80 100 - 2.89 3.49 2.87 20.68 -
- 2.81 100 2.81 100 2.82 100 2.81 100 
- 2. 77 53 .10 2.77 78. 10 2.79 80.76 -
2.72 49.09 - - - 2.76 62.07 
2.64 21.74 2.71 63.50 2. 72 82.86 2. 72 72.97 2.73 78.71 
- - 2.63 44.69 2.63 33.86 -
2.54 6.81 2.61 22. 10 - 2.59 14. 13 2.61 28.61 
- 2.52 6.50 2.53 10.48 2.53 8.89 2.5l 7.36 
- - - 2.39 3.58 2.39 2.11 
2.34 5. 15 - 2.34 6.98 2.34 7.65 2.34 3.86 
- 2.29 6.90 2.30 11.43 2.30 9.86 2.29 7.82 
2.26 18.56 2.26 22.00 2.26 39.74 2.26 29. 10 2.25 30.26 
- 2.23 3.20 2.23 4.63 2 .18 4.82 -
2. 14 7.57 2 .16 7.50 2 .15 11. 74 2 .15 10.34 2 .14 8.55 
- - - - 2. 10 2.20 
2.06 7.58 2.06 6.00 2.06 10.79 2.06 10.89 2.06 6.99 
2.03 9.09 2.04 2.50 2.02 14.85 2.02 18.41 2.03 12.69 
2.00 6.81 2.00 5 .10 2.00 8.38 2.00 8.76 2.00 5.70 
1.94 23.40 1. 94 27.50 1. 94 50.35 1.94 . 35.31 1.94 34.96 
1 .89 14.31 1.89 19.00 1.89 24.69 1 .89 20.69 1.89 16.74 
- 1.86 5.40 1.86 9.65 1.87 9.03 1.87 5.97 
1.84 27.42 1.83 30 .10 1.83 58.44 1.84 45.31 1.83 28.33 
1 .80 16. 51 1.80 16.00 1.80 29.58 1.80 20.07 1.80 20.42 
1. 78 12.87 1.77 12.40 1. 77 22.54 1.78 14.21 1. 78 16.09 
1. 75 13.63 1.75 1~.60 1.75 23.61 1. 75 16.55 1. 75 15.63 
1.72 15.07 1. 72 14.00 1. 72 26. 15 1. 72 16.69 1. 72 16.74 
Listing of ct-spacings vs intensities for the bones after heating 
to 650°C 
1 2 3 4 5 6 
d I d I d I d I d I d I 
4.11 14.60 4. 12 12.90 4.11 13. 16 4. 14 13.27 4.11 12.67 4.07 13. 14 
3.91 13.09 3.91 12.34 3.89 13.26 3.98 13 .18 3.91 13.75 3.89 13.89 
3.44 37.41 3.44 33.68 3.45 37.85 3.44 31.41 3.44 34.28 3.45 34.55 
3.19 14.96 3. 18 14.03 3 .18 14.49 3.20 15.04 3 .19 14.73 3 .17 14.27 
3. 10 29.64 3.09 10.57 3.09 20.41 3.11 21.'95 3. 10 21.43 . 3.08 20.65 
2.83 100 2.82 100 2.81 100 2.84 100 2.82 100 2.81 100 
2. 72 90.95 2.73 58.56 2.73 55.51 2. 72 67.30 2.71 59.73 2. 72 57.65 
2.64 28.20 2.66 23.38 2.63 24.59 2.65 25.57 2.65 24 .10 2.64 23.66 
2.54 10.79 2.55 8.84 2.52 9.48 2.54 11.68 2.54 10.53 2.53 9.57 
. 
2.35 7.48 2.36 13. 19 2.37 11.73 2.35 12.39 - 2.35 9.38 
2.27 11 • 15 2.27 23.29 2.29 22.75 2.28 26.28 2.30 24.38 2.26 22.53 
2.15 12.37 2.16 9.35 2.17 9.08 2 .15 13 .98 2 .15 11.78 2 .15 9.38 
2.06 7.23 2.07 7.48 2.08 8.47 2.08 13.36 2.07 11 .42 2.06 8.35 
2.03 12.44 2.04 22.83 2.04 19.59 2.03 19.46 2.03 11.42 2.03 12.95 
2.00 6.69 2.00 7.84 2.02 8.57 - 2.00 10.35 2.00 17.37 
1.95 10.43 1. 93 25.01 1. 95 25.51 1.95 30 .17 1.95 27 .13 1.94 24.32 
1.90 18.06 
1.88 9.92 1.88 15.88 1.89 15.71 1.90 19.47 1.90 17.32 1.89 15.58 
1.85 36.73 1.84 27. 16 1.85 29.08 1.85 31.68 1.84 28.57 1.84 26.48 
1 • 81 27.91 1.80 17.73 1.80 18.36 1.81 23.00 1.81 10.08 1.80 18. 78 
1.78 30.80 1. 77 15.40 1.78 15.82 1.79 20 .oo . 1. 79 17.41 1. 78 16. 15 
1. 76 18.71 1.76 14.00 1.76 14.79 1.76 17.69 1.76 15.17 1.76 14.27 
1. 72 15.82 1. 71 14.00 1. 72 15.30 1. 73 16.81 1. 72 14.28 1. 72 13.99 
Listing of d-spacings vs intensities for the bones 
to 900 °C 
after heating 
1 2 3 4 5 6 
d I d I d I d I d I d I 
4.09 15.51 4. 11 15.41 4.09 13. 72 4. 12 12.81 4.09 16.41 4.11 13.59 
3.89 13.04 3.91 14.44 3.91 13.64 3.94 11.87 3.91 15.28 3.89 11 . 81 
- 3.53 10.22 3.53 9.73 3.54 11 .33 3.53 10.58 3.51 8. 15 
3.45 37.02 3.45 49.48 3.44 45.49 3.45 30.63 3.44 41.66 3.44 37.22 
3. 19 14.47 3. 19 15.92 3. 19 15.52 3.20 17.58 3. 19 15.02 3 .18 12.35 
3.09 31. 10 3.09 32.22 3 .10 28.78 3.11 28.51 3.09 30.39 3.09 28.87 
2.81 100 2.82 100 2.83 100 2.83 100 2.83 100 2.82 100 
2.77 63.89 2.79 77.03 2.79 73.80 2.80 59.37 2.79 72.92 2.76 64.52 
2.71 86.74 2.73 81.85 2.73 90.58 2.73 83.59 2.72 93.45 2.73 91.75 
2.63 28.91 2.64 36.22 2.64 34.51 2.64 30.86 2.64 33 .19 2.64 29.11 
2.59 7.05 2.61 15.63 
2.52 11.14 2.54. 11.34 2.54 10.04 2.54 17.58 2.54 10.92 2.54 9.62 
- - 2.41 6. 11 - - 2.40 3.41 
2.34 8.81 2.34 9.57 2~35 19.24 - 2.34 8.21 2.34 3.88 
2.29 10.58 2.30 11.48 2.30 10.98 2.31 19.38 2.30 12.05 2.30 9.94 
2.27 42.67 2.27 42.70 2.26 14.98 2.27 44.61 2.27 43.23 2.26 40.52 
- 2.24 5.52 2.23 5.49 - - 2.23 4. 19 
2.14 12.55 2 .15 13.25 2. 15 12. 15 2 .16 27.89 2 .15 13.27 2. 15 11.33 
2.07 7.54 2.11 4.07 2.11 4.78 2 .13 42.26 2. 11 4.45 2. 11 3 .41 
- 2.06 9 .12 2.06 9.09 2.07 30.39 2.06 9.43 2.06 6.98 
2.04 15.58 2.03 18.77 2.03 19.21 2.03 30.54 2.02 12.66 2.03 4.65 
2.00 6.20 2.00 7.36 2.00 7.84 2.01 30.54 2.00 8.21 2.00 6.21 
1 .95 41.68 1.95 46.53 1. 95 44.00 1.95 54.68 1.94 46.81 1. 94 41. 14 
1.89 19.74 1.89 22.08 1.89 21.96 1.90 31.64 1.89 23 .14 1.89 20 .10 
1.87 10.51 1.87 9. 72 1.87 9.02 1.88 23.43 1.87 10.56 1.87 9.31 
1. 84 37.66 1.84 46.53 1.84 46.27 1.85 50.47 1.84 47.25 1.84 39.20 
1.80 29. 12 1.81 30 .. 18 1 • 81 28.00 1 .81 36.56 1.80 31.61 1 .81 27.63 
1. 78 22.92 1. 78 22.45 1.78 21.80 1.78 30.46 1.78 24.80 1. 78 21.29 
1. 76 18.82 1.76 20.84 1.76 20.39 1. 76 26.56 1.76 21.92 1. 76 19.01 
1. 72 14.95 1. 72 20.02 1. 72 20.47 1. 72 23.83 1. 72 19.83 1. 72 15.91 
